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Zusammenfassung 
 
Das Endothel spielt nicht nur eine wichtige Rolle im Verlauf von Arteriosklerose, 
sondern auch in anderen inflammatorischen Erkrankungen wie Vaskulitis. 
Endotheliale Aktivierung wird durch abnormale Scherspannung, lokale Entzündung 
sowie Chemokinausschüttung ausgelöst, gefolgt von der Hochregulierung von 
Zelladhäsionsmolekülen wie beispielsweise das intrazelluläre Adhäsionsmolekül 1, 
das vaskuläre Zelladhäsionsmolekül 1 und Selektine. Diese Zelladhäsionsmoleküle 
fördern die Migration von Immunzellen und sind für den Verlauf von Entzündungen 
verantwortlich. Diese Moleküle werden ebenfalls hochreguliert nach vaskulären 
Intervention wie z.B. Ballonangiographie mit Stent Implantation und 
Endoarteriektomie. Während der endothelialen Wundheilung ist ein Blutgefäß 
anfällig für Thrombusformation sowie Akkumulation von Immuzellen und Restenose. 
Erkrankungs- und verletzungsbedingte Biomarker werden auf der luminalen 
Oberfläche exprimiert und stellen ein potentielles Ziel für die Bildgebung und 
Diagnostik dar. Das Hauptziel dieser Studie war die Etablierung eines vaskulären 
Kontrastmittels, welches den physiologischen Fluss- und Scherraten in Hauptarterien 
widerstehen kann und dabei gleichzeitig spezifisch an molekulare Marker bindet. 
Klinische Bildgebungsmethoden haben nur unzureichende Sensibilität und 
Auflösung, um einzelne Partikel zu verfolgen. Daher wurde die Zwei-Photonen 
Mikroskopie als eine präklinische optische Bildgebungsmethode verwendet, welche 
tief ins Gewebe eindringen kann, um das Expressionsmuster von Oberflächenmarkern 
und das Bindungsverhalten von Mikrobläschen zu charakterisieren.  
Mikrobläschen (MB) sind mit Luft gefüllte und auf Polymer basierende Partikeln mit 
einem durchschnittlichen Durchmesser von 1-2 µm. Diese wurden, erstmals unter 
niedrigen Flussbedingungen, erfolgreich in der Tumor-Bildgebung etabliert,  am 
Beispiel vom vaskulärem endothelialen Wachstumsfactor-Rezeptor (VEGFr). Die 
Beladung der Partikel mit Fluoreszenzfarbstoffen ermöglicht die bi-modale Detektion 
der Partikeln mit molekularem Ultraschall und Zwei-Photonen Mikroskopie. Mithilfe 
von Zwei-Photonen Mikroskopie wurde die Scherspannung-Resistenz von ICAM-1 
spezifischen MB auf TNFα-stimulierten Karotiden in einer ex vivo Flusskammer 
charakterisiert. Nicht nur unter physiologischen Bedingungen, sondern auch bei weit 
höheren Scherraten sind gebundene MB zu beobachten. In dieser ersten proof-of-
  
concept-Studie wurde die potentielle Anwendung von MB in entzündeten 
Hauptarterien gezeigt. 
Durch die vaskuläre Intervention wird das Endothel, welches die Dysfunktion der 
regulatorischen Mechanismen verursacht schwer beschädigt. Dies erhöht unter 
anderem das Risiko für Thrombose und Restenose. Die endotheliale Regeneration 
nach der Intervention ist ein lebenswichtiger Schritt für die volle Genesung von 
Patienten. Das vaskuläre Zelladhäsionsmolekül 1 wird nach endothelialer Verletzung 
auf den glatten Muskelzellen überexprimiert. Während der akuten Entzündungsphase 
wird dieser Marker sowohl auf regenerierenden Endothelzellen als auch auf den 
glatten Muskelzellen exprimiert. Mit einsetzender Bedeckung der glatten 
Muskelzellen durch Endothelzellen, verschwindet VCAM-1 von der endothelialen 
Oberfläche, was diesen Rezeptor zu einem perfekten Marker für die endotheliale 
Regeneration macht. Mithilfe von Zwei-Photonen Mikroskopie wurden einzelne MB 
im Lumen verfolgt, quantifiziert und eine spezifische Bindung festgestellt. Mithilfe 
von molekularem Ultraschall wurde die Bindung der MB an das verletzte Endothel 
ebenfalls detektiert. Datenanalyse haben ergeben dass Ultraschall zwischen 
verschiedene Phase der Endothelregeneration unterscheiden kann und damit eine 
akkurate Prognose des endothelialen Zustandes geben, welches in Korrelation mit 
Immunhistologie und 3D-Rekonstruktion der luminalen Oberfläche steht. 
  
 
Summary 
 
The endothelium plays an important role, not only in the progression of 
atherosclerosis, but also vasculitis and other inflammatory diseases. Endothelial 
activation triggered by abnormal shear stress, local inflammation and chemokine 
release is followed by the upregulation of surface adhesion molecules, such as 
intercellular adhesion molecule 1, vascular cell adhesion molecule 1 and selectins. 
These surface adhesion molecules facilitate the migration of immune cells, 
responsible for the elicitation of inflammation. Similarly, injury related inflammation 
is induced during interventional surgery such as balloon angioplasty with stent 
implantation and endoarterectomy. During the process of endothelial regeneration, the 
blood vessel is vulnerable to thrombus formation, immune cell accumulation and 
restenosis. 
Disease- and injury-associated biomarkers are expressed on the luminal surface of 
major arteries and pose a potential target for imaging and early diagnosis. In this 
study, the main aim was to establish a vascular contrast agent that can withstand 
physiological flow and shear stress conditions in major arteries while specifically 
binding to a molecular target long enough for imaging. Clinical imaging modalities 
lack sufficient sensibility and resolution for tracking single particles. Two-photon 
laser scanning microscopy (TPLSM) was applied as a deep-tissue imaging modalities 
for the characterization of surface marker expression and binding kinetics of 
rhodamine-loaded microbubbles as a preclinical step towards translation. 
Microbubbles, a polymer-based air-filled particles with the diameter of 1-2 µm (MB) 
have been previously established in tumor imaging, which are able to attach to the 
vascular endothelial growth factor receptor at relatively low flow rates. Fluorescent 
loading of the MB shell promotes the bimodal detection of the particles both using 
TPLSM and molecular ultrasound. Using TPLSM imaging on TNFα stimulated 
explanted murine carotid arteries in an ex vivo flow chamber system, the shear stress 
resistance of intercellular adhesion molecule 1 targeted MB were characterized at 
shear rates matching and exceeding physiological conditions, showing its potential 
imaging application in inflamed major arteries in this first proof-of-concept study.  
During vascular intervention, the endothelium is severely injured and inflamed, 
resulting in dysfunction of the regulatory mechanisms of the endothelium, increasing 
  
thrombosis and restenosis risk. Endothelial regeneration following intervention is a 
crucial step towards full recovery of patients. Vascular cell adhesion molecule 1 is 
expressed after endothelial denudation on the medial smooth muscle cells, during the 
acute inflammation phase on both the smooth muscle layer and regenerating 
endothelial cells, but disappears from the endothelial layer after recovery, making it 
the perfect molecular marker to track endothelial healing. Using in vivo TPLSM, 
single MB bound to the vascular lumen was imaged and quantified showing specific 
retention. Translation into molecular ultrasound confirmed injury-specific MB 
retention and accurate prediction of the endothelial state in correlation with 
immunohistology and TPLSM imaging of the luminal surface. 
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1 Introduction  
 
Fluorescence microscopy is a heavily used tool in many fields of today´s biomedical 
research for the investigation of complex and dynamic processes in tissue, cells, and 
even subcellular compartments, with extraordinary spatial and temporal resolution. Its 
importance is stressed by a seemingly endless list of applications from simple lab 
routine histology to in vitro live cell imaging, over to intravital imaging and finally 
also whole body fluorescence imaging. Nonetheless, the evolution to the microscopes 
known today took centuries, starting from a simple one-lens translumination 
microscope in 1674 developed by Antonie van Leeuwenhoek, the first fluorescence 
microscope used by Oskar Heimstaedt in 1911, to the confocal microscopes applied 
by Marvin Minsky in 1957. It was not until the 1990s before the first two-photon 
based microscope was developed by Winfried Denk and colleagues. In the last 20 
years, numerous other microscopy techniques were developed, such as super-
resolution microscopy techniques, Coherent anti-Stokes Raman Spectroscopy 
(CARS), optical coherence (OCM) and photoacoustic microscopy (PAM) . 
For two-photon based microscopes, the theory of two-photon quantum transition in 
atoms was already established in 1929, decades before its first application by the 
physicist Maria Goeppert-Mayer in her doctoral dissertation in Goettingen [1]. She 
postulated that the simultaneous absorption of multiple low-energy photons with the 
total energy of that of a single high-energy photon would lead to the excitation of 
fluorescent molecules as well. However, due to the lack of laser sources with high 
(peak) powers and tunability, it took 60 years and the invention of femtosecond lasers 
for the translation from theory into practice [2]. Denk and colleagues demonstrated 
the capabilities of two-photon laser scanning microscopy (TPLSM) for biological and 
biomedical research. Ever since then, TPLSM has been embraced by the science 
community and implemented into a broad spectrum of biomedical research fields 
including oncology [3], neurology [4], dermatology [5], immunology [6] and 
cardiovascular research [7]. 
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1.1 Basic Principles of fluorescence Excitation 
 
Parts of the following section have been published as: 
Z. Wu & M. van Zandvoort. Two-photon microscopy. In Comprehensive Biomedical Physics (MEPH), 
Elsevier B.V. 2014:4:165-74. 
 
The first fluorescence microscope was introduced in 1911 by Oskar Heimstaedt, using 
ultraviolet excitation light. It is based on the ability of an atom to change its electronic 
energy state by the absorption or emission of photons. The electronic energy state of 
an atom and the probability of such an energy state transition event can be calculated 
using quantum mechanics. Before photon emission/luminescence can occur, there has 
to be absorption of a photon to promote an optical transition to an excited state. These 
events occur at the sites of molecules containing chromophores such as nowadays 
commonly used fluorophores: fluorescein isothiocyanate (FITC) and rhodamine B. 
Each chromophore has an individual excitation spectrum, displaying its dependency 
of emission on excitation wavelength (Figure 1). Wavelength is given in nanometers, 
and the energy of photons is inversely proportional to their wavelength (Equation 1).  
 
E =
hc
λ
 
 
Equation 1. Planck-Einstein relation. E = Energy, h = Planck’s constant, c = speed of light, 
λ = wavelength. 
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Figure 1. Excitation and emission of fluorophores. A) Excitation spectra of FITC (green) and 
Rhodamine B (red). B) Emission spectra of FITC and Rhodamine B. C) Chemical structure of FITC 
and Rhodamine B. 
1.1.1 Linear optical microscopy 
 
Parts of the following section have been published as: 
Z. Wu & M. van Zandvoort. Two-photon microscopy. In Comprehensive Biomedical Physics (MEPH), 
Elsevier B.V. 2014:4:165-74. 
 
In more details, polyatomic molecules, as common fluorophores, have distinct energy 
states, which depend on multiple parameters: 1) the configuration of its electrons, 
2) the vibrational motion of the nuclei and 3) the rotational motion of the molecule 
itself. The electron configuration or electronic state of an atom can be regarded as 
either singlet (Sn) or triplet (Tn). The S or T state of an atom depends on the spin 
configuration of its electrons, as discovered by Stern and Gerlach in 1922 and is either 
positive (up-spin) or negative (down-spin). The term spin refers to the intrinsic 
rotational property (angular moment) of electrons generating magnetic moments 
parallel or antiparallel to the magnetic field of the atom. Typically in atoms, the 
electrons are located in such a way that in each pair of electrons, one has up-spin and 
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the other has down-spin resulting in a net spin of zero (singlet state). It is called 
singlet state, because there is only one state with total spin of zero. However, there are 
exceptions such as O2, which at room temperature has a pair of electrons with the 
identical spin configuration resulting in a net spin of 1 (triplet state), where the name 
triplet state refers to the three different spin configurations that result in the net spin of 
1.     
The various energy levels involved in the absorption, relaxation and emission of 
photons by a fluorophore are classically presented by a Jablonski energy diagram 
(Figure 2).  
 
Figure 2. Jablonski diagram of fluorescence and phosphorescence (adapted from  Jaboski et al. [8] ) 
 
At room temperature, all electrons of a fluorophore remain in singlet ground state S0 
and the lowest vibrational level. The excitation of a fluorophore and emission of 
photons follows multiple steps. In step 1, a photon of given energy/wavelength is 
provided from a light source such as a laser. The fluorophore in its singlet ground 
energy state S0 is converted into one of the excited states S1 or S2 by the absorption of 
a photon, promoting an electron into a higher-energy orbit. Since the absorption event 
is not associated with a spin change, the molecule remains in a singlet but excited 
energy state. During step 2, the molecule undergoes a vibrational relaxation process, 
during which the molecule transfers excess vibrational energy to the surrounding 
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molecules in the form of heat. At the end of the relaxation process the molecule has 
returned to the lowest vibration level of S1. Each electronic state (S0, S1, S2) has 
various vibrational levels and all of them can be reached after excitation. The third 
and final step is the relaxation of the molecule from the lowest vibrational state of S1 
to one of the vibrational levels of S0. The relaxation can be non-radiative, during 
which the vibrational energy is transferred as heat to the surrounding molecules, or 
the relaxation can be radiative in the form of fluorescence and phosphorescence. The 
energy of the fluorescence emission photons is equal to the energy difference ΔE 
between the lowest vibration level of the excited state and the involved vibrational 
level of the ground state. As a result of energy loss in step 2, the emitted photon has 
lower energy than the absorbed photon, leading to a shift between excitation 
wavelength and emission wavelength referred to as Stokes shift [9].  
Each step is associated with a certain temporal delay: 1) absorption occurs in 10-15 s, 
2) relaxation in 10-12 s – 10-10 s and 3) emission 10-10 s – 10-7 s also referred to as 
fluorescence lifetime. The fluorescence lifetime of a molecule is dependent on various 
factors, such as pH, ion concentration and temperature, but also the intrinsic 
properties of the molecule itself. Phosphorescent materials for examples do not reemit 
the photons it absorbs immediately. The phosphorescence process is a relative slow 
process which involves the transition from the single ground energy state into the 
excited triple state T1 involving a change of spin state (intersystem crossing). The 
triplet states have lower energy levels than corresponding excited single states and 
much lower decay rates, emitting photons at longer wavelengths than fluorescence 
and with a delay from milliseconds up to minutes or hours after excitation[10, 11]. 
1.1.2 Non-linear optical microscopy 
 
Parts of the following section have been published as: 
Z. Wu & M. van Zandvoort. Two-photon microscopy. In Comprehensive Biomedical Physics (MEPH), 
Elsevier B.V. 2014:4:165-74. 
 
In 1931, Maria Goeppert-Mayer described a process called two-photon (TP) 
excitation, during which multiple photons of low energy can promote the same 
transition of a molecule from ground to excited state that is normally induced by the 
absorption of a single high energy photon [1], such as described in the previous 
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paragraph. Although in theory, the numbers of photons involved in the excitation 
process can be more than 2 and do no necessarily have to inhere the same amount of 
energy (same wavelength), it is common for TP excitation to use a single laser 
providing photons with the same wavelength and energy. In comparison to linear 
single-photon confocal microscopy, where molecules are excited using UV/visible 
wavelengths (350 – 650 nm), TP excitation is non-linear, involving the absorption of 
two (near) infrared (NIR) (~800 - 1000 nm) photons to promote the transition from 
ground to excited energy state. As energy of the photons is inverse proportional to its 
wavelength, the excitation wavelength of TP lasers is approximately twice the 
wavelength as required for single photon excitation.  
The two-photon excitation can be shown as a two-step process. Single photons in TP 
excitation do not promote the transition from S0 to S1 due to their lower energies, 
therefore the excitation process requires an intermediate state after the absorption of 
the first of two photons. This step is called virtual transition. Only when the second 
photon is absorbed within attoseconds (10-18 s), the molecule can undergo the 
transition to excited energy state. The relaxation and emission process is identical to a 
single-photon event [11]. As a result of the two photons interacting with the molecule 
instead of one, the transition rate of two-photon absorption is proportional to the light 
intensity squared (non-linear dependency), as opposed to the linear dependency of 
single photon excitation. Consequently a doubling of photon intensity produces four 
times the fluorescence (Equation 2).  
R =σ (ω)I 2  
Equation 2. Non-linear effect of two-photon excitation (Boyd 1992). R = transition rate of two-
photon absorption, σ = two-photon absorption cross-section, I = photon intensity, ω = energy of 
excitation photon. 
 
The likelihood of a TP excitation event depends on two factors: 1) the spatial and 
temporal availability of excitation photons, 2) the two-photon cross-section of the 
excited molecule, referring to its physical properties favoring TP absorption. 
Typically, the number of TP excitation events is extremely low. To increase the 
number of excitation events, high numerical aperture objectives are used in order to 
focus the laser beam, thereby increasing photon intensity at the focal point. 
Nonetheless, focusing does not yield an excitation probability high enough for 
adequate fluorescence imaging. An additional increase of excitation probability is 
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provided by a laser which emits ultra-short (femtosecond) pulses with high peak 
intensities [10]. Commonly used and commercially available setups use a mode-
locked titanium sapphire (Ti:Sa) femtosecond laser working at a frequency of 80 
Mhz. Although the photon density is extremely high during the pulse, the average 
power output is lower compared to continuous lasers, which reduces photobleaching 
of probes and damage to tissues and cells. 
Non-linear optical microscopy has two major advantages over conventional linear 
optical microscopy: 1) Suppression of out-of-focus excitation and 2) superior tissue 
penetration. Due to the low excitation probability, fluorophore excitation events only 
occur in the focal plane, where photon density is the highest. This does not only 
improve spatial resolution but also confines phototoxicity (Figure 3A). Tissue 
penetration is achieved by reducing scattering events [12]. In clear tissue, all 
excitation photons reach the focal point for both linear and non-linear setups. 
However, near infrared light is much less prone to scattering than wavelength from 
the visible spectral range, therefore does not lead to an exponential decrease of 
excitation events with increasing depth [13]. Scattering NIR photon density is too low 
to generate any fluorescence signal, in fact, due to the principle of non-linear 
excitation, fluorescence emission can only occur from the focal plane (Figure 3B). 
 
 
Figure 3. Linear versus non-linear excitation. A) Excitation volume is confined during non-linear 
excitation, while linear excitation generate significant out-of-focus excitation. B) Near infrared light is 
less sensitive to scattering and penetrate deeper into scattering tissue, (adapted from Helmchen F. & 
Denk W.,[14]). 
 
Besides fluorescence excitation, a different phenomenon in non-linear optical 
imaging, referred to as second harmonic generation (SHG), is frequently used for 
(label-free) imaging [15]. Contradictory to the two-photon excitation process, SHG is 
a scattering process in which two photons interact simultaneously with a non-
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centrosymmetric target, leading to the emission of a single scattered photon with 
exactly twice the energy (frequency doubling) i.e. half the wavelength. Consequently, 
with an incident wavelength of 800 nm, the SHG signal is 400 nm (blue) [16]. Only 
deeper in tissues this might cause insufficient SHG to be detected, since the 
backscattered light is absorbed or scattered by the tissue. Biological non-
centrosymmetric structures are collagen fibers, actin filaments in skeletal muscle 
fibers, and cardiomyocytes.  
1.1.3 Optical imaging modalities 
 
Parts of the following section have been submitted for publication as: 
Z. Wu, T. Rademakers, F. Kiessling, M. Vogt, E. Westein, C. Weber, R.T.A. Megens, M. van Zandvoort. 
Non-linear Laser Scanning Microscopy in Cardiovascular Research. Cardiovasc Res. 
 
The majority of life-threatening cardiovascular events, including myocardial 
infarction and stroke, are triggered by atherosclerosis, which is characterized by a 
chronic inflammation of the blood vessel wall, accumulation of oxidized lipoproteins, 
leukocytes, and T-cells, and leading to remodeling and expansion of the blood vessel 
walls to form atherosclerotic plaques. These ultimately may cause blockage of blood 
flow by thrombosis and embolization upon plaque rupture [17] or stenosis. 
Thrombotic events are the major cause for atherosclerosis-related complications [18].  
The goal of atherosclerosis-related (vital) imaging in animals is to further unravel the 
complex morphological, functional, and molecular mechanisms associated with 
disease progression and ultimately lead to novel clinical prevention, detection, and 
intervention strategies. Despite technological and diagnostic advances, the complex 
molecular mechanisms underlying the pathogenesis of atherosclerosis are still not 
fully elucidated. Continuous innovations in noninvasive (clinical) imaging 
technologies, including magnetic resonance imaging (MRI), computed tomography 
(CT), nuclear imaging, and ultrasound, provide highly-detailed (sub-mm) anatomical 
and functional information of the human cardiovascular system. However, both in 
human and animal studies these modalities lack cellular specificity and the ability to 
provide insight on disease-related cellular and molecular processes, as each of them is 
associated with drawbacks such as low sensitivity, low spatial resolution, and low 
signal-to-noise ratio [19].  
1     Introduction 
 
9 
Optical imaging techniques offer a spatial resolution superior to the conventional 
clinical modalities and therefore allow not only the detailed assessment of tissue 
morphology, but can also provide insights on tissue composition and cellular marker 
expression at a molecular level, which is crucial for clinical translation. However, 
optical techniques offer limited penetration depth in tissue, with invasiveness as a 
consequence. Currently, multiple optical imaging techniques such as optical 
coherence tomography (OCT) [20], and photoacoustic tomography (PAT) [21, 22] are 
being used for imaging in human atherosclerosis. Application of OCT and PAT 
imaging in cardiovascular tissues are well described in several other reviews [23, 24], 
including their limitations regarding sensitivity, resolution, and penetration depth 
(Figure 4).  
 
 
Figure 4. Comparison of optical imaging modalities. Non-linear laser scanning microscopy as a 
bridge modality. 
 
Optical microscopic techniques (see Figure 4) such as confocal microscopy, non-
linear laser scanning microscopy, and, more recently, optical nanoscopic techniques 
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(STED, PALM, STORM) [25], photoacoustic microscopy (PAM) [26], and Optical 
Coherence Microscopy (OCM) [27],  have found their specific fields of application in 
cardiovascular research.  
Regarding resolution, penetration and field of view, TPLSM inheres a unique position 
between sub-cellular mechanistic research and whole body imaging, bridging basic 
research and preclinical imaging. Its inherent properties streamline the 
characterization and development of novel markers, drugs and contrast agents from in 
vitro to ex vivo and in vivo in a single modality. Non-linear laser scanning microscopy 
is being applied to assess cardiovascular disease in vivo in animals and ex vivo on 
human tissue [28-32]. It has favorable properties that overcome many of the 
limitations of conventional single-photon imaging modalities, such as lack of out-of-
focus fluorescence, better penetration depth, and reduced photo-toxicity, photo-
activation, and photobleaching [6, 7]. The combination of high spatial 3D resolution 
and superior penetration depth (up to 1 mm, dependent on tissue type) has been 
frequently used to study intact tissue and provide information on a cellular and 
subcellular level therein [14]. More importantly, it allows the acquisition of 
functional, structural, and molecular information simultaneously in intact tissue and 
organs, which offers the opportunity to study processes in their physiological 
environment. This is particularly important for atherosclerosis, a disease associated 
with both structural and functional alterations [33]. Most recently, in vivo non-linear 
laser scanning microscopy has been successfully applied on carotid arteries and the 
heart, tracking single cells in three dimensions over time under high flow and shear 
stress conditions, overcoming the technological challenges that arise with the imaging 
of strong moving tissue types [34],[35]. Besides classical non-linear microscopic 
systems, a variety of systems are currently being developed as the basis for preclinical 
and clinical image-guided diagnostics and therapies such as photodynamic therapy 
(PDT) and photothermal therapy (PTT). Consequently, a bigger field of view, higher 
penetration and optical sectioning on top of in vivo application promotes non-linear 
laser scanning microscopy to become a bridging modality between basic research and 
clinical translation (Figure 4). 
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1.2 Two-photon imaging in biomedical research 
 
Parts of the following section have been published as: 
Z. Wu & M. van Zandvoort. Two-photon microscopy. In Comprehensive Biomedical Physics (MEPH), 
Elsevier B.V. 2014:4:165-74 
 
TPLSM is widely used for broad application spectrum in the biomedical field. The 
main advantages of two-photon microscopy are 1) the localized excitation focal 
volume, 2) multi-dye imaging and 3) dye-free second harmonics generation (SHG). 
Not only does a localized excitation reduce out-of-focus fluorescence and increase 
penetration depth, it also confines phototoxicity and photobleaching to the focal 
plane. The use of near infrared (NIR) wavelength increases tissue penetration while 
simultaneously decreasing tissue damage. Multi-dye imaging increases the number of 
channels possible using a single excitation wavelength without the use of filter wheels 
and can be advantageous for interaction studies between cells or subcellular 
components. In addition to TP autofluorescence, the non-linear interactions with 
biological tissue compounds allow label-free imaging, such as collagen imaging using 
SHG. These advantages have established TPLSM as a valuable tool for deep tissue 
imaging ex vivo, in vivo, and in long-term measurements. 
Working with vital tissue has one distinct advantage, it reduces the probability of 
artifacts that accompany the various steps of histology and immunohistochemistry 
(cutting, fixation, processing, staining) [36]. TPLSM has been used successfully on a 
wide range of viable tissue ex vivo, but also in vivo, such as brain [37-39], kidney [40-
45], lymphoid tissue [46-50], tumors [51, 52] and other fields (Figure 5 A & B). Even 
strong pulsing major blood vessel can be imaged under physiological conditions [33] 
(Figure 5 C). TPLSM is also used in cellular studies, (where normally it is not advised 
due to worse resolution compared to confocal microscopy) for several reasons: 1) 
imaging of second harmonic generation of collagen or myosin, 2) simultaneous probe 
excitation and 3) autofluorescence imaging [53, 54]. 
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Figure 5. TPLSM imaging of different organ and tissue types. A) Mouse kidney tissue (red = nucleus 
stain, SYTO 17, green = glomerulus). B) 150 µm z-stack of mouse colon cancer xenograft (red = blood 
vessel staining using rhodamine-lectin). C) Mounted and pressurized ex vivo mouse carotid artery. 
Image shows a z-directional cut into the carotid artery displaying various layers of smooth muscle cells 
(red – SYTO 17) in the arterial wall and longitudinal endothelial cells on the luminal side. Scale bar = 
50 µm. 
 
One of many fields in which TP has been proven its value is cardiovascular research, 
especially in atherosclerosis. The combination of high-resolution imaging and deep 
tissue penetration afforded many insights on the composition of atherosclerotic 
plaques. It is possible to determine structural and functional alterations in the arterial 
wall, which may lead to the progression of vascular diseases such as atherosclerosis. 
Especially exploiting SHG generation, as collagen is one of the major components of 
blood vessel walls and plays an important role in the progression of atherosclerotic 
plaques and other cardiovascular diseases such as hypertension and age-related 
arterial stiffness [55-57]. In addition to atherosclerosis studies, SHG of collagen has 
been used to shed light into the different stages of myocardial infarction in vital heart 
tissue, providing structural and quantitative information regarding healthy, infarcted 
and regenerating hearts [58]. The investigation of vascular and cardiac remodeling 
and plaque development has been the focus of many cardiovascular-related studies 
using TPLSM [29, 59-63].  
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1.3 Imaging of atherosclerosis 
 
Parts of the following section have been submitted for publication as: 
Z. Wu, T. Rademakers, F. Kiessling, M. Vogt, E. Westein, C. Weber, R.T.A. Megens, M. van Zandvoort. 
Non-linear Laser Scanning Microscopy in Cardiovascular Research. Cardiovasc Res. 
 
The progression of atherosclerosis is a slow and steady process. In order to understand 
the dynamic process that determines the onset and development of a dense structure 
like a plaque, a modality with high sensitivity, subcellular resolution and deep tissue 
penetration is required. Molecular, structural, and functional imaging with subcellular 
resolution enables the visualization of biomarkers, morphological changes, and signal 
molecules. All these characteristics are essential for the accurate visualization of 
disease progression and the development of adequate intervention and prevention 
strategies.  
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Figure 6. Examples of intravital atherosclerosis (A-E) and heart (F) imaging. A) Imaging of major 
arteries after endothelial injury (dashed lines show the outline of the elastin layers) showing cell debris 
in the luminal side of the blood vessel (white arrows) and subendothelial expression of the 
inflamational marker VCAM-1-AF568 (red) in comparison to B) a healthy blood vessel with an intact 
endothelial layer (green) labeled using CD31-AF488. C) Both collagen and elastin can be imaged 
without labeling using autofluorescence or SHG, repetitively. These structures can be visualized better 
after the addition of dyes, e.g., D) elastin (white arrow) staining using sulfo-rhodamines (red) in a 
murine blood vessel or E) collagen staining using CNA35-FITC (green) in plaque containing carotid 
artery where enhanced accumulation can be observed in the plaque shoulder region. Images were 
modified from Richard et al. 2007 and Megens et al. 2007 [64], respectively. F) heart imaging of 
myocardial tissue showing resident macrophages (yellow box) and neutrophils (blue box) – modified 
from Li. et al. 2012  [65]. Scalebar = 50 µm. 
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1.3.1.1 Major arteries 
 
Arterial walls are composed of three layers: tunica intima, tunica media, and tunica 
adventitia. The intima, the most inner layer closest to the lumen, is a relatively thin 
layer which consists of the basal membrane that is covered by a single layer of 
endothelial cells which in turn is covered by the endothelial glycocalyx (EG) [59, 66]. 
The intima acts as a semi-permeable barrier controlling migration of cells and proteins 
into and out of the bloodstream. It has been shown that the endothelial layer and 
glycocalyx have antithrombotic, anti-inflammatory, on top of vasomodulatory 
functions, controlling platelet adherence and activation, and vasodilatation [67] by the 
secretion of substances such as nitric oxide (NO). One  of the targets for imaging of 
early stages of atherosclerosis development is endothelial dysfunction [28], which is 
considered one of the key events in the onset of atherogenesis. Reitsma et al. studied 
the relation between endothelial glycocalyx thickness and platelet adhesion during 
atherogenesis [28, 59, 68]. While in wild type B6 mice, the glycocalyx thickness 
increases with age, no such change was observed for mice with apolipoprotein E 
knock-out (ApoE-/-). Furthermore, in vivo TPLSM studies have shown that during 
atherogenesis, platelet adhesion was significantly increased at the same location, 
where EG growth was hampered [28], stressing the atheroprotective properties of the 
EG and potential glycocalyx-reinforcement therapies for the prevention of disease 
progression. The spectrum of functional imaging of atherosclerosis using TPLSM 
[69-71] has recently been extended to the visualization of NO production within 
diseased tissue ex vivo [72]. Using a copper-based fluorescent probe, NO production 
in carotid arteries and aortas were directly and specifically visualized. Using TPLSM 
3D sectioning, it was possible to differentiate between NO positive endothelial and 
smooth muscle cells and even to semi-quantitatively determine the amount of NO 
produced in each cell. The altered NO production as a consequence of endothelial 
dysfunction results in a number of cardiovascular symptoms such as hypertension and 
atherosclerosis [73]. The combination of an NO-sensitive fluorescence probe and 
TPLSM can thus provide valuable information regarding the structural-functional 
relationship of NO production in the vessel wall with direct visualization of the 
structure and location of NO producing, shedding light onto the role of NO during 
vascular dysfunction.  
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Additionally, the dysfunction of both barrier and secretory functions is accompanied 
by the luminal presence and release of chemokines and cytokines [74], and 
overexpression of cell adhesion molecules, such as intercellular adhesion molecule 
(ICAM), vascular cell adhesion molecule (VCAM), junctional adhesion molecule A 
(JAM-A) [75], platelet endothelial cell adhesion molecule (PECAM/CD31), and 
selectins [76, 77]. These processes cause an increased accumulation of inflammatory 
cells, such as monocytes, neutrophils, and T cells, as well as lipids in the vessel wall. 
Both cell adhesion molecules and chemokines/cytokines can potentially be used as 
molecular markers for early stages of lesion development using optical imaging 
techniques. The detection of molecular disease markers such as inflammatory 
receptors requires a method with high sensitivity (such as antibody-coated fluorescent 
beads [78]), as their concentration is expected to be in the nanomolar range. This is 
especially true for markers in the subendothelial space, as probes will only penetrate 
the intima to a limited extend. Two-photon imaging using fluorescence and NIR 
excitation, has shown its potential as a high-resolution and highly sensitive imaging 
method for atherosclerosis in preclinical studies in small animals, both ex vivo and in 
vivo [7, 29, 30, 33, 79] (Figure 6A & B). Furthermore, potential therapeutic 
approaches using novel contrast agents and drug carriers can be characterized and 
evaluated by visualizing cellular binding, retention and uptake. Applying TPLSM, 
quantitative analysis of probe binding efficiency, shear stress resistance, and 
distribution can be performed, providing the stepping stone for the transition to 
clinical non-invasive imaging modalities. 
In the later stages of atherogenesis, the secretion of chemokines and surface adhesion 
molecules promote the recruitment and migration of monocytes to the site of 
inflammation, which is a very dynamic and complex immunological process. It has 
been shown that in vivo TPLSM offers the possibility to follow leukocyte recruitment 
to the plaque [29]. The detailed characterization of monocyte recruitment and plaque 
growth is essential for the understanding of disease progression and the development 
of adequate prevention therapies [80]. 
The detailed characterization of morphological and functional changes in the arterial 
wall, on a cellular and subcellular level, contributes greatly to our existing 
understanding of disease progression (Figure 6).  Furthermore, the development and 
characterization of novel molecular probes using TPLSM imaging is 
beneficial/crucial for the development of multi-modal contrast agents for noninvasive 
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clinical imaging modalities with shortcomings in spatial resolution or sensitivity, such 
as molecular ultrasound, MRI, CT, and PET/SPECT. 
 
1.3.1.2 Imaging of ECM 
 
In addition to the molecular and functional imaging possibilities, TPLSM is a highly 
favorable imaging modality for structural visualization of the extracellular matrix 
components (ECM) of vessel walls. The tunica media of blood vessels consists mostly 
of layers of smooth muscle cells separated by elastin and collagen fibers, while the 
major component of the most outer layer (tunica adventitia) is collagen [81]. Collagen 
plays an important role in the progression of atherosclerotic plaques and other 
cardiovascular diseases such as hypertension, age-related arterial stiffness, atrial 
fibrillation, and myocardial fibrosis [55-57, 82]. Its extensive contribution to and 
impact on vascular remodeling and plaque development has been reviewed by 
Adiguzel et al in 2009 [83]. In cardiac tissue, the main source of SHG comes from 
cardiomyocytes themselves. In the cardiomyocytes, next to the collagen, the 
myosinfilaments are an intense source of SHG. During lesion progression, the vessel 
wall undergoes structural remodeling steps, such as the increase of the intima-media 
thickness (IMT), alteration of the endothelial glycocalyx thickness [28, 59], increased 
smooth muscle cell proliferation, and collagen synthesis, increased vasa vasorum in 
the tunica adventitia [84]. ECM-related proteins such as collagen and endothelial 
fibrin [64, 85, 86] could serve as markers for studying atherosclerotic cap formation 
and cap thinning. 
Collagen has been the focus of many cardiovascular-related studies using non-linear 
microscopy [60, 64, 87, 88], for once because of its importance in the cardiovascular 
disease progression and also because collagen can be easily imaged without 
exogenous application of dyes by using second harmonic generation (Figure 6 C). The 
non-centrosymmetric surface of certain (fibrosis) types (I & III) of collagen  scatters 
the excitation light, providing photon emission without photobleaching [89]. The 
complex mechanisms and dysfunctional balance of collagen synthesis and 
degradation during atherogenesis has a major impact on disease progression. Collagen 
content can spike up to 60% of total plaque proteins, therefore contributing 
significantly to plaque growth and arterial narrowing in fibrous lesions. Alternatively, 
collagen degradation in the fibrous cap makes the plaque vulnerable and prone to 
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rupture. It should be noted, however, that only specific types of collagen such as 
collagen I, III, IV, V, and VIII along the subendothelial layer are actively involved in 
plaque development and rupture [83, 90]. However, SHG detection becomes more 
difficult when moving deeper into the tissue, since SHG is mainly forward scattered 
and as such backward (epifluorescence) detection is not efficient, creating the need 
for collagen specific dyes. As demonstrated in a study by Megens et al in 2007, the 
collagen-marker CNA35 was characterized and established using TPLSM, as a 
molecular marker for atherosclerotic plaques in ApoE-/- mice, mainly based on the 
endothelial uptake and distribution of the collagen-marker. Due to characteristic 
increase of endothelial permeability and elevated collagen content in the lesion areas, 
CNA35 showed significantly higher binding compared to healthy tissue (Figure 6 E). 
Additionally, CNA35 shows potential application for other diseases, such as liver and 
kidney fibrosis. Furthermore, ECM such as elastin can also be visualized with 
exogenous staining (e.g. using Sulforhodamine B or Eosin, Figure 6 D) as well as 
without exogenous staining (autofluorescence), making TPLSM an even more 
attractive imaging modality to study ECM (Figure 7 A & C). It has been shown by 
Lilledahl et al. that solely based on the elastin/collagen ratio, atherosclerotic plaques 
could specifically be identified [91]. 
 
1.3.1.3 Imaging of the heart 
 
Similar to arterial atherosclerosis, myocardial inflammation and ischemia are the 
precursors to clinical symptoms and complications. Earlier studies using TPLSM 
were limited to ex vivo Langendorff-perfused hearts [92-94]. In vivo two-photon 
imaging of the heart has been gaining interest since many fields of research, also 
atherosclerosis research, would benefit greatly from subcellular imaging of the heart 
in vivo. Yet, the heart is being more affected by severe motion artifacts than any other 
organ, and as such it is one of the most challenging organs to apply in vivo two-
photon microscopy on. Only recently, a first attempts have been made to visualize a 
beating mouse heart in vivo at a subcellular resolution. Li et al were able to perform in 
vivo TPLSM imaging on a beating heart using a system involving heterotopic 
transplants and an imaging chamber [34, 95] (Figure 6 F) . The migration and 
extravasation of monocytes into the inflamed coronary blood vessels and cardiac 
tissue could be studied for up to 3 hours. In vivo TPLSM allows the tracking of single 
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cells and the quantification of cell migration parameters, such as rolling velocities, 
crawling velocities, and the direction of displacement after extravasation.  In vivo 
imaging of the heart has been further refined by Lee et al [96], who elegantly 
combined existing triggering methods with a heart stabilizing tool that suppresses part 
of the motion of the beating heart inside the pericardial cavity. The impressive result 
is high resolution imaging of the intact in vivo mouse heart for studies with a duration 
of >4 hours. It can be expected that especially the latter method will prove to be a 
powerful tool and will strongly contribute to our understanding of the morphology, 
physiology, and pathophysiology of the heart, especially when combined with 
imaging systems allowing even faster acquisition rates and more sensitive detection. 
1.4 Bridging non-linear imaging and clinical imaging 
 
When choosing the clinical translational tool, one has to consider the pros and cons of 
each medical imaging modalities and its suitability regarding resolution, penetration, 
invasiveness and cost for its intended application field. Schmidt et al. 2013 [97], 
analyzed commonly used clinical imaging modalities for vessel inflammation such as 
atherosclerosis, injury and vasculitis (Table 1). 
 
Table 1. Clinical imaging modalities for vessel imaging (adapted from Schmidt W.A.,[97]). 
Diagnostic 
test Economical 
Non-
invasive 
Depicting artery 
wall 
Non-
radiative 
Temporal 
arteries 
Angiography + - - + - 
Ultrasound ++ ++ ++ + ++ 
CT + + ++ - - 
CT-angio + + - - - 
MRI + + ++ - ++ 
MR-angio + + - - + 
PET - + - - - 
 
Compared to MRI, PET and CT, Ultrasound is the most common and economical and 
bed-side available imaging modality, that allows non-radiative live-imaging [98]. 
However, without contrast enhancement, functional and molecular imaging is not 
applicable. In order to achieve sufficient resolution and sensitivity to detect early 
signs of vascular inflammation, a contrast agent is needed. 
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During disease progression, the endothelium plays a crucial role. Common to the 
pathogenesis is the abnormal activation of immune cells and vascular endothelium, 
which is the primary targeting area for the molecular contrast agent. Agent size has a 
major impact on pharmarcokinetics, surface functionalization possibilities and 
immunogenicity, which implies a trade-off of characteristics of different formulation 
for its intended purpose. 
 
Figure 7. Size dependent pharmacokinetics of imaging agents (adapted from Kiessling F.,[99] ) 
 
Nano-sized contrast agents (MRI and PET agents) tend to internalize into tissues and 
accumulate unspecifically over time, thereby reducing the signal-to-noise ratio 
(Figure 7). Micro-sized particles such as microbubbles (MB), which have been used 
for contrast-enhanced ultrasound [99], have a size of 1-2 µm are too big to extravasate 
and stay exclusively intravascular. Additionally, a doubling in particle radius 
increases particle surface by the factor of four, giving micro-sized particles a much 
higher surface density of targeting ligands. On the general down side, bigger particles 
have a rather low blood half life and are more susceptible to luminal shear stress and 
collisions with blood components. However, a short circulation time is favorable for 
molecular ultrasound [100]. The quantification of contrast enhancement occurs via a 
destructive ultrasound pulse wave, rupturing all MB in the field of view. Rapid 
clearance improves the signal to noise ratio, leaving only specific bound MB behind. 
This method of detection and quantification has been successfully applied in tumor 
imaging targeting VEGFR in small vessel with low flow [101].  
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1.5 Study aims 
 
Imaging of major blood vessels is a highly challenging task. Blood flow and shear 
stress on contrast agents are high, rendering binding difficult. The endothelium is the 
primary target and plays a prominent role in the early stages of atherosclerosis and 
other vascular inflammatory diseases such as vasculitis. Additionally, clinical 
intervention surgeries such as balloon angioplasty, endarterectomy and stent 
placement severely injury the blood vessel inducing local inflammation. As a result, 
activated endothelial cells upregulate surface adhesion molecules, such as vascular 
cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) 
that can initiate leukocyte recruitment and transmigration, thereby contributing to the 
plaque growth [102-104] in the case of atherosclerosis and neointima formation after 
intervention. These distinct adhesion molecules can be utilized for molecular imaging 
purposes.  
In this context, due to the fact that these are intravascular markers, ultrasound 
molecular imaging with target-specific µm-sized gas bubbles (which stay strictly 
intravascular) present a suitable method for the imaging of endothelial dysfunction. 
However, molecular imaging of activated endothelium in major vessels, such as 
carotid arteries is a daunting task due to the high flow and shear rates. Therefore, 
ultrasound molecular imaging studies on atherosclerosis have tried to overcome these 
obstacles by various methods, including: modulating the microbubbles (MB) surface 
coverage with ligands [105], using multiple targeting ligands [106] etc., mostly in 
vitro on cell cultures. So far, in vivo binding assessment of targeted MB has been 
limited to the aortic arch [107], which characteristically has a larger diameter (up to 3 
fold) and significantly lower shear stress than carotid arteries [108]. 
The aim of this investigation is to show that Contrast-Enhanced Ultrasound (CEUS) 
using targeted MB can be applied for molecular imaging of carotid incipient 
atherosclerosis at physiological flow and shear rates. Polymeric MB have been shown 
to be suitable contrast agents for functional and molecular ultrasound imaging [109]. 
The target of choice was ICAM-1 because of its physiological relevance in the early 
stages of plaque development [110] but also because of its Tumor Necrosis Factor 
alpha (TNFα) dependent upregulation [111]. Using ICAM-1-targeted and rhodamine-
labeled MB [112], the binding of MB to inflamed endothelial surfaces was 
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systematically investigated under different flow and shear-stress conditions, 
visualized by CEUS and quantitatively validated by Two-Photon Laser Scanning 
Microscopy (TPLSM). These results serve as a proof of concept that CEUS with 
targeted MB can be performed in carotid arteries and stress the appropriateness of 
TPLSM as validation method in tissues. Furthermore, in a more clinically oriented 
mouse model of endothelial denudation, similar to balloon angioplasty, we apply the 
same principle using VCAM-1 as a marker for endothelial regeneration, in order to 
establish a method for non-invasive endothelial tracking. 
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2 Material and Methods 
2.1 Materials 
The general chemicals were bought from Sigma-Aldrich, Merck or Fluka in analytical 
grade quality. All solutions were prepared with double distilled water (Heraeus 
Destamat, Heraeus, Germany), Millipore water (Milli-Q Plus ultrapure purification, 
Millipore, MA) or with Aqua ad injectabilia (Braun, Melsungen, Germany). The 
general equipment, consumables and kits are mentioned below.  
2.1.1 Lab equipment 
  
Centrifuges Eppendorf 5417C (Eppendorf, Hamburg, Germany), Heraeus 
Fresco 21 (Heraeus, Osterode, Germany), Beckman Avanti 
J30I (Beckman Coulter, Krefeld, Germany) 
 
Flow cytometer FACS Calibur (BD Biosciences, San Jose, CA, USA) 
Multisizer 3  Beckman Coulter GmbH, Krefeld, Germany 
Microscope Axio Imager M2 fluorescence microscope (Carl Zeiss AG,  
Jena, Germany) 
Multiphoton Olympus FV1000 PME Multiphoton Microscope (Olympus 
Deutschland GmbH, Hamburg, Germany) 
Leica SP5 (Leica Microsystems, Wetzlar, Germany) 
pH-meter InoLab level 1 (WTW, Weilheim, Germany) 
Peristaltic pump Minipuls Evolution (Gilson Inc, Middelton, WI, USA) 
Stirrer Ultra-Turrax T50 Dissolver (IKA Werke GmbH, Staufen, 
Germany) 
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2.1.2 Consumables 
 
Culture slides  BD, FranklinLakes, USA 
Disposable 
Syringes  
Terumo, Leuven, Belgium; Braun, Melsungen, Germany; BD, 
FranklinLakes, USA  
FACS-tubes BD, FranklinLakes, USA 
Falcon tubes (15 
and 50 mL) 
Greiner Bio-one, Frickenhausen, Germany 
Pipettes (5,10 and 
25 mL) 
Corning, New York, USA 
Sterile filter tips Starlab, Ahrensburg, Germany 
2.1.3 Buffers and Solutions 
 
0.1 M HCL 1M HCl (stock) diluted 10x in aqua-dest 
0.1 M NaOH 1M NaOH (stock) diluted 10x in aqua-dest 
Cell medium Endothelial cell growth medium II; 10% fetal bovine serum; 
1% gentamicin (Gibco, Life Technologies GmbH, Darmstadt ) 
FACS buffer 1% BSA - 0.01% Triton X100 - PBS buffer solution: 500 mg 
BSA, 50 µl 10% (w/v) Triton X100 solution, 50 mL sterile 
filtered PBS (Gibco ,Life Technologies GmbH, Darmstadt)  
Hank’s complete 10X HBSS (Invitrogen,Carlsbad, USA) 0.5 M EDTA, 0.6%; 
10% BSA. 
HEPES/Triton 
Buffer 
30 mL of 5 M NaCl solution and 10 mL of HEPES solution 
(Gibco Life Technologies GmbH, Darmstadt) are filled to 
1000 mL with 0.01% (w/v) Triton solution. 
Sodium acetate 
Buffer 
Solution A: 1.36 g NaOOCCH3·H2O (M = 136, 1 g/mol) was 
dissolved in 500 mL of aqua-dest. Solution B: 571 µl Acetic 
acid (M = 60, 1 g/mol) was mixed with 500 mL aqua-dest. 
400 mL of solution A was set to a pH of 4.5 using solution B. 
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2.1.4 Miscellaneous reagents 
 
Alexa Fluor 562 succinimidyl ester Life technologies (Carldbad, CA, USA) 
DAPI Vector (Burlingame, CA, USA) 
ECGM II Gibco (Darmstadt, Germany) 
EDC Sigma-Aldrich (St. Louis, USA) 
Fetal bovine serum (FBS)  Gibco (Darmstadt, Germany) 
Gentamycin Gibco (Darmstadt, Germany) 
Hepes Gibco (Darmstadt, Germany) 
Oregon green 488 succinimidyl ester Life technologies (Carldbad, CA, USA) 
Paraformaldehyde Sigma-Aldrich (St. Louis, USA) 
PBS Gibco (Darmstadt, Germany) 
SYTO 16 Life technologies (Carldbad, CA, USA) 
SYTO 41 Life technologies (Carldbad, CA, USA) 
Streptavidin Applichem (Darmstadt, Germany) 
TNFα Peprotech (Hamburg, Germany) 
Wheat germ agglutinin OG488 Life technologies (Carldbad, CA, USA) 
2.1.5 Antibodies 
 
Name mAB Clone Company 
In vivo/ex vivo 
CD31 rat anti-mouse MEC 13.3 BD Pharmingen 
CD54 rat anti-mouse YN1/1.7.4 eBioscience 
CD106 rat anti-mouse 429 eBioscience 
Immunohistology 
CD54 rat anti-mouse YN1/1.7.4 Santa Cruz 
CD62P goat polyclonal C-20 Santa Cruz 
CD62E goat polyclonal M-20 Santa Cruz 
CD31 goat polyclonal M-20 Santa Cruz 
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2.2 Methods 
 Parts of the following section have been published as: 
Z. Wu, A. Curaj, S. Fokong, E.A. Liehn, C. Weber, T. Lammers, F. Kiessling, M. van Zandvoort. 
Rhodamine-loaded ICAM-targeted microbubbles for dual modality imaging under controlled shear 
stresses. Circ Cardiovasc Imaging. 2013;6(6):974-81(* equal contribution). 
2.2.1 Microbubbles synthesis and characterization 
2.2.1.1 Synthesis of rhodamine-loaded microbubbles 
 
Rhodamine encapsulated poly (n-butyl cyanoacrylate) (PBCA) MB were synthesized 
as follows. 3 mL of monomeric butyl-2-cyanoacrylate (BCA; Special polymer ltd.) 
were added drop wise to 300 mL of an aqueous solution of 1 % Triton X-100 (Sigma-
Aldrich) at pH 2.5. Subsequently, rhodamine-B, was dissolved in 300 µL of distilled 
water and added to the mixture. Using an Ultra Turrax, the mixture was then stirred 
for 60 minutes at 10000 rpm. The resulting rhodamine-loaded MB suspension was 
washed several times by flotation to remove the excess rhodamine and polymer 
fragments. 
In order to wash excess debris of polymerization, oversized (> 2 µm diameter) and 
undersized (<1 µm diameter) particles, the MB suspension was transferred to a 50 mL 
falcon to undergo size isolation via centrifugation. Using a Heraeus Multifuge 1 L 
with a radius of 10 cm from the center of the rotor to the center, the suspension was 
centrifuged at 500 rpm for 5 min. The resulting MB layer at the top of the falcon was 
carefully transferred into a fresh falcon and resuspended in an aqueous solution 
containing 0.02% (w/v) Triton X-100. The size distribution was analyzed using a 
Multisizer 3 (Beckmann Coulter GmbH, Krefeld, Germany). 
For the conjugation of Streptavidin (Applichem) to the MB surface, the surface ester 
groups were partially hydrolyzed. To achieve a 10% hydrolysis, MB were suspended 
in a 0.1 N NaOH solution. Subsequently, the MB were diluted in 15 mL of sodium 
acetate. Streptavidin was conjugated to the MB by a 1-ethyl-3-(3-
dimethylaminopropyl)carbidiimide hydrochloride (Sigma Aldrich) reaction between 
the amine group of the streptavidin and the carboxylic group of the MB surface, using 
7.5 mg of EDC and 300 µg of Streptavidin. After an 1h incubation at room 
temperature and an overnight incubation under mild stirring at 4 ºC, the MB are 
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isolated flotation. Size distribution and MB concentration were determined with the 
particle counter Multisizer 3 (Beckman-Coulter). 
 
2.2.1.2 Microbubble characterization 
 
The labeling efficiency of the MB surface using streptavidin was evaluated using flow 
cytometry. 50 µL of streptavidin conjugated MB (5x108 MB/mL) were incubated with 
increasing amounts (1, 5, 25, 150 ng/mL) of biotinylated fluoresceinisothiocyanate 
(FITC-biotin) for 20 min in order to investigate the saturation level of Streptavidin-
MB. Excess FITC-biotin was removed by centrifugation using a Heraeus Fresco 21 
(Thermo Fischer Scientific) at 2000 rpm for 2 min. The MB were analyzed using a 
fluorescence activated cell sorter (FACS) FACS Calibur (BD Biosciences). In order 
to estimate the amount of bound FITC-biotin per MB, a calibration curve was 
established by measuring eight peak rainbow calibration beads with known levels of 
fluorescence (molecules of equivalent fluorescein). The calibration beads consists of 
particles with eight different but known fluorescence intensities. The mean 
fluorescence channel number for each bead population was determined using FACS 
histograms and using to create a standard curve, using which the number of bound 
FITC-biotin molecules per MB was estimated. 
2.2.1.3 Microbubble antibody labeling 
 
1x107 streptavidin-coated MB in HEPES/Triton buffer (pH 7.0) were mixed with 5 µg 
of biotinylated ICAM-1 antibodies and incubated at room temperature for 30 minutes. 
The conjugated MB were separated from excess antibodies by centrifugation 
(500 rpm for 2 min) and re-suspended in 100 µL HEPES/Triton buffer. 
2.2.2 In vitro MB binding assay 
2.2.2.1 Cell culture 
 
Human umbilical vein endothelial cells (HUVEC), purchased from ATCC, were 
grown and maintained in endothelial cell growth medium (ECGM II), supplemented 
with 10% (v/v) heat inactivated fetal bovine serum, endothelial cell growth 
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supplement and 1% (v/v) gentamicin at 37°C in a 5% CO2 humidified atmosphere. 
All reagents were purchased from Promocell. 
2.2.2.2 TNFα stimulation 
 
100 µl of HUVEC were seeded (1x106 cells/mL) on collagen-coated 35-mm Petri 
dishes and maintained for 36 h until full confluency. The optimal concentration for 
cell stimulation was determined using gradually increasing amounts of TNFα 
(PeproTech) at 10, 20, 40 and 80 ng/mL. Using ICAM-1 as the indicator of cellular 
inflammation, the cells were fixed with 4% paraformaldehyde in PBS (pH 7.4) after 
4 h of incubation and stained. The cells were stained for ICAM-1 using a Alexa Fluor 
562 (AF562) labeled primary antibody. For orientation and analysis, the endothelial 
glycocalyx (EG) on the membrane and nucleus were incubated with wheat germ 
agglutinin Alexa Fluor 488 and DAPI, respectively for 45 min and washed with 1 mL 
of PBS pH 7.4. 
2.2.2.3 In vitro flow chamber binding assay 
 
100 µl of HUVEC were seeded (1x106 cells/mL) on collagen-coated 35-mm Petri 
dishes and maintained for 36 h until full confluency. The cells were incubated with 
40 ng of recombinant human TNFα (PeproTech) for 4 h prior to MB perfusion. The 
cells were incubated with WGA-AF488 (1:1000)(EG staining) and SYTO 41 
(1:1000)(nucleus staining) (Invitrogen) for 45 min and then washed with 1x PBS. The 
Petri 35-mm dishes were mounted into a customized parallel wall flow chamber in a 
custom silicon tube closed perfusion system (standard silicon tubing 0.76 mm inner 
diameter – Helixmark). Using a peristaltic pump (Gilson Inc), a continuous flow rate 
of 0.25 mL/min was set. 1x107 ICAM-conjugated MB were injected into the 
perfusion system and a closed loop circulation was performed for 10 minutes, 
followed by a 10 min washing step using 1x PBS with an open loop. Fluorescence 
images were obtained subsequently using an Axio Imager M2 fluorescence 
microscope (Carl Zeiss AG, Germany) and z-stack images were obtained using an 
Olympus FV1000MPE multiphoton microscope. 
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2.2.2.4 TPLSM imaging 
 
The Olympus FV1000 MPE system (Mai Tai DeepSee pulsed Ti:Sapphire laser with 
140 fs pulsewidth at an excitation wavelength of 800 nm and a 25x water dipping 
objective (NA = 1.05 , WD = 2 mm) has three internal photon multiplier tubes, which 
were used to detect the fluorescence signals, and filters were adjusted to the 
corresponding spectra: 390 – 460 for DAPI, 490-540 for WGA-AF488 and 590 – 620 
for Rhodamine-B. Z-stacks were imaged at a step size of 1 µm. TPLSM images were 
analyzed using Image-Pro Analyzer 7.0 software (Media Cybernetis, Inc.) and Imaris 
software (Bitplane).  
2.2.3 Ex vivo MB binding assay and immunhistology 
2.2.3.1 Murine model of endothelial activation 
 
All animal experiments were approved by local authorities and complied with 
German animal protection law. Endothelial activation was induced in eight-week-old 
male CD-1 wild type mice via intraperitoneal (i.p.) injection of recombinant murine 
TNFα (PeproTech) 0.067 mg/kg. Non-stimulated and TNFα-stimulated mice  were 
sacrificed by i.p. injection of anesthetic overdose (400 mg/kg ketamine, 40 mg/kg 
xylazine) 4 h after TNFα injection and both (left and right) common carotids excised 
by a cervico-toracal incision.  
2.2.3.2 Ex vivo artery mounting and perfusion 
 
Mice were sacrificed by i.p. overdose injection of anesthetic. The common carotid 
arteries (6-7 mm) were excised and freed from adipose and connective tissue, without 
damaging the blood vessel. Handling of the blood vessel was restricted only to both 
ends. In order to avoid air bubbles within the lumen, the blood vessels were preserved 
at 4°C in 1x Hanks Balanced Salt Solution (HBSS, pH 7.4, Life technology) before 
the mounting procedure. Each excited carotid was mounted in a customized flow 
chamber, filled with HBSS (37°C) [113]. The carotid was mounted on each side onto 
glass pipettes (tip diameter 120-150 µm). Luminal blood residues were removed by 
carefully flushing with 1x HBSS to avoid endothelial activation. In order to correct 
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for shortening and deflation of the carotid, the blood vessel was pressurized 
(60 mmHG) and stretched. Fresh blood collected from healthy volunteers was anti-
coagulated with heparin (10 U/ml) - EDTA (1.2 - 2 mg EDTA/mL) and infused 
through the carotids at a flow rate of 0.25 mL/min for 2 min.  
 
Figure 8. Customized flow chamber setup. A) The flow chamber with a mounted carotid artery. B) 
The imaging setup using a peristaltic pump simulating the pulsed circulation. 
 
All flow experiments were conducted at 37°C using flow rates ranging from 0.25 
mL/min to 1 mL/min (0.25, 0.6, 0.8 and 1 mL/min in a custom silicon tube perfusion 
system using (Standard Silicon Tubing 0.76 mm inner diameter – Helixmark) and 
flow was established using a peristaltic pump in the same direction as under 
physiological conditions. Either targeted or control MB (107 mL-1), suspended in 
whole blood, were infused for 10 min, followed by 10 min washing using human 
blood (ex vivo ultrasound investigations were performed without removing the 
circulating MB). For competitive binding studies, the TNFα stimulated carotid was 
perfused with 20 fold higher concentration of free ICAM antibody (100 µg, 2 µg/µL) 
for 10 min before MB injection. The carotid was then imaged using CEUS or 
TPLSM. The number of animal used (n) was 20. 
2.2.3.3 TPLSM imaging 
 
The carotid artery within the flow chamber was imaged using an Olympus 
FV1000MPE multiphoton microscopy system (Mai Tai DeepSee pulsed Ti:Sapphire 
laser with 140 fs pulsewidth at an excitation wavelength of 800 nm and a 25x water 
dipping objective (NA = 1.05 , WD = 2 mm). Three internal photon multiplier tubes 
were used to detect the fluorescence signals, and filters were adjusted to the 
corresponding spectra: 390 – 460 for collagen second harmonic imaging, 490-540 for 
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elastin autofluorescence and 590 – 620 for rhodamine. TPLSM images were analyzed 
using Image-Pro Analyzer 7.0 software (Media Cybernetis, Inc.) and Imaris software 
(Bitplane).  
2.2.3.4 Vessel diameter estimation and shear stress calculation 
 
 
Figure 9. Model of vessel diameter estimation by van Triest et al. 2010[114] . A) x-z view of a z-stack 
recorded of the top of a mounted carotid artery. B) Schematic view of the estimation algorithm using t 
= tangent, r = radius, m = midpoint. 
Vessel diameter estimation was performed as described in Van Triest et al. (2010) 
[115] (Figure 9). Accordingly, shear stress for each carotid was calculated based on 
the Haagen-Poisseuille equation (Equation 3). Blood viscosity at 37°C was estimated 
at 0.004 Pa*s. 
 𝜏 = 32 ∗ 𝜇 𝑄𝜋 ∗ 𝑑! 
 
Equation 3: Haagen-Poiseuille’s law for blood flow within a vessel (inelastic, cylindrical and 
straight). τ = shear stress, µ = mean flow velocity, Q = men volumetric flow rate, d = vessel diameter. 
Methods  
32  
 
2.2.4 Mouse model, in vivo imaging 
Parts in the following section have been accepted for publication as; 
Z. Wu*, A. Curaj*, S. Fokong, E.A. Liehn, C. Weber, A. Burlacu, T. Lammers, M. van Zandvoort, F. 
Kiessling. Noninvasive molecular ultrasound monitoring of vessel healing following intravascular 
surgical procedure in a preclinical setup. ATVB. (* equal contribution). 
2.2.4.1 Wire-injury surgery 
 
All animals were started on high fat diet (0.25 % cholesterol, SDS) 1 week prior to 
commencement of the protocol. The Lindner wire injury model was utilized: 
endothelial denudation of the common carotid using a flexible wire. This model is 
used commonly in rodents [116]. A flexible wire is inserted from the carotis externa 
into the carotis communis removing the endothelial layer. Permanent ligation of the 
left carotis externa will be performed leading the blood flow from the heart only 
through the carotis interna in our wire injury groups. In detail, after general anesthesia 
is induced the operation field is shaved. Loose fur is removed by vacuum cleaner and 
the skin is washed with isopropanol. A 1.5 cm long medial incision is made in caudo-
cranial direction at the collar region at the left lateral side. The common carotid and 
the bifurcation area were dissected. Threats were placed around the most caudal part 
of the common part of the common carotid artery (CCA), the external carotid artery 
(ECA) (2 threads) and the internal carotid artery (ICA). The ECA was ligated with the 
cranial thread. Both the CCA and the ICA were occluded by pulling and fixing the 
ends of the threads on the operating table. The ECA was incised caudally of the 
ligature and a 0.36 mm thick guide wire was advanced into the CCA (about 7 – 
8 mm). Wire withdrawal injury was performed by 3 passes along the common carotid 
artery with rotating motion. After removing the guide wire, the ECA was occluded 
with the second thread caudally of the incision. The threads around the ICA and CCA 
are removed and the blood-flow reestablished. The wound was closed with suture 
clips. Physiological vascular injury is associated with hyperlipidemia, hypertension, 
obesity and smoking. Injury to the arterial intima results in the formation 
of atherosclerotic plaques and smooth muscle cell activation associated with 
neointimal hyperplasia. The wire injury model mimics the progress of restenosis after 
angioplasty and shows reproducible plaque development. 
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2.2.4.2 In vivo TPLSM 
 
Animals were anesthesized using Ketamine (100 mg/kg) and Xylazine (10 mg/kg) 
and are placed in the supine position. Body temperature was kept at 37°C by means of 
a heating pad. The left carotid is surgically exposed up to the bifurcation. To simplify 
between artery and surrounding tissue, a thin black plastic sheet was placed 
underneath the artery segment without stretching the vessel (Figure 10 A). Exposed 
areas are kept moist with saline at all time during the experiment. For MB injections, 
a catheter made of a 28 mm polyethylene tubing fitted with a 30 G needle was 
inserted into the tail vein. All catheter were filled with heparin (5 U/mL in saline). 
30 mins prior to imaging, 0,5 nM SYTO 13 was applied superficially on the top of the 
exposed carotid in order to stain the vessel adventitia for orientation within the tissue.  
 
 
Figure 10. Experimental setup of in vivo TPLSM imaging. A) Surgical preparation of the animals. 
B) In vivo image of the carotid artery. C) The carotid connecting heart and brain has an 20%-25% 
angle, leading to a tilted focal plane. As a result the TPLSM single plane images show a parabolic 
shape. 
 
TPLSM imaging was performed using a Leica SP5 (Leica Microsystems, Germany) 
with an integrated resonance scanner for high-speed imaging and a Compact Ultrafast 
Ti:Sapphire Laser (Chameleon, Coherent, USA) at an excitation wavelength of 
800 nm and a 20x water dipping objective (NA = 1.0, WD = 2 mm, with optical zoom 
capability). In vivo imaging was performed at a frame size of 400 x 400 pixels at a 
scan rate of 8000 Hz and line averaging of 2 for noise reduction, resulting in a final 
imaging speed of 10 frames per second (Figure 10 B). Due to anatomical location of 
the carotid artery, the objective is not rectangular to the artery (Figure 10 C), resulting 
in the parabolic shape of vessel wall (Figure 10 B). For time-lapse recording, a series 
of 500 images or 55 second of video material was recorded. After the injection of 
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4x107 MBVCAM-1, the carotid was imaged for 15 min. The animals were sacrificed 
after in vivo imaging and additional ex vivo carotid imaging at higher resolution was 
performed, as described above 
2.2.4.3 In vivo Ultrasound 
 
Mice with wire-injured carotids were investigated by molecular US imaging at 
different time points (1 , 3 , 7  and 14 d). In vivo molecular US measurements were 
performed using a small animal high frequency US system (Vevo 770) and a 45 Mhz 
linear transducer. MB-specific signals were acquired and color-coded overlays on B-
mode images were performed using the contrast mode provided by the vendor. Each 
measurement was done with the mouse under anesthesia (1% isoflurane) with the 
mouse placed on a heated table (Vevo Mouse Handling Table). One dose of 2x107 
MBVCAM-1 or MB control (MBCTR) were injected intravenously via a cannulated 
tailvein while under US imaging. Seven min after injection, US imaging in contrast 
mode was performed as described above to measure the difference in the signal levels 
before and directly after a destructive pulse [117]. For competitive binding studies at 
1 d after wire-injury, intravenous injection of 20-fold higher concentration of free 
anti-CD106 antibody (100 µg, 2 µg/ul) was applied for each mouse 10 min before 
MBVCAM-1 injection to block VCAM-1- binding sites. An imaging sequence of 60 
seconds (10 frames/second) was acquired. To distinguish signal from retained MBs 
alone, several imaging frames post-destruction representing freely circulating MBs 
were averaged and subtracted from several averaged pre-destructive frames 
(representing the cumulative signal of circulating and bound MBs).  
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3 Results 
3.1 MB synthesis and characterization 
 
The polymeric microbubbles were synthesized from the monomer n-
butylcyanoacrylate, which polymerizes under high cavitation forces, leading to the 
encapsulation of air during MB formation. Fluorescence markers and other molecules 
can be loaded into the shell of the MB, when added during the polymerization process 
or even after. The size distribution directly after synthesis ranges between 0.75 µm – 
5 µm. 58% of MB are distributed between 1 - 2 µm, while submicron particles make 
28% of the newly synthesized bubbles (Figure 11 A). For a more monodispersed 
population, the MB were size isolated using centrifugation. The result was a 78% 
population of 1 – 2 µm-sized MB and 19% oversized MB, while all submicron MB 
were removed (Figure 11 B). 
 
 
Figure 11. MB size distribution before and after size isolation. A) Size distribution curve of a MB 
batch before and after centrifugal size isolation. B) size distribution in percentage. C) TPLSM images 
of rhodamine-loaded MB. Scalebar = 5 µm. 
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3.2 Streptavidin coating 
 
The functionalization of MB requires a ligation handle for the attachment of targeting 
peptides to the particle surface. Prior to surface functionalization with Streptavidin, 
the surface ester groups of PBCA were partially hydrolyzed (10%) using 0.1 N NaOH 
in order to facilitate 1-ethyl-3-(3-dimethylaminopropyl)carbidiimide hydrochloride 
reaction between the amine group of the streptavidin and the carboxylic group of the 
MB surface.  
 
Figure 12. MB labeling saturation with increasing FITC-biotin concentrations. 
 
In order to validate Streptavidin coating and quantify the amount of binding spots 
available, flow cytometry was performed. Using increasing amounts of biotinylated 
FITC starting at 1 ng, up to 800 ng, MB binding saturation was investigated. Based on 
fluorescence intensity shift with increasing FITC-biotin concentration, no significant 
increase could be observed between 25 ng and 150 ng of FITC-biotin, indicating 
saturation (Figure 12). Further experiments were carried out with 25 ng of FITC-
biotin (Figure 13 A). In order to estimate the number of FITC molecules bound per 
MB, two parameters are needed: 1) The mean fluorescence channel number (MFCN) 
and 2) molecules of equivalent fluorescein (MEFL). Using eight peak rainbow 
calibration particles with known levels of fluorescence as standards, the MFCN for 
each fluorescence intensity of the calibration particles was determined via FACS 
quantification and used to establish a calibration line with the given MEFL (provided 
by vendor) of the particles (Figure 13 B). After FACS measurement of MBFITC the 
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MFCN was calculated using the geometric mean value of the fluorescence 
distribution and the MEFL on the MBFITC could be determined and translated into the 
number of FITC molecules per MB. 
 
Figure 13. Mean fluorescence channel number calibration using flow cytometry. A) FACS histogram 
of MBFITC. B) FACS histogram of eight peak rainbow calibration particles. 
 
It was estimated that approx. 95 streptavidin molecules are conjugated to the MB, 
resulting in 380 active binding spots (Figure 14). 
In vitro MB binding assay  
38  
 
Figure 14. Schematic representation of targeted rhodamine-loaded microbubbles. 
3.3 In vitro MB binding assay 
 
Parts of the following section have been published as: 
Z. Wu, A. Curaj, S. Fokong, E.A. Liehn, C. Weber, T. Lammers, F. Kiessling, M. van Zandvoort. 
Rhodamine-loaded ICAM-targeted microbubbles for dual modality imaging under controlled shear 
stresses. Circ Cardiovasc Imaging. 2013;6(6):974-81(* equal contribution). 
 
The binding efficiency of particles in vivo depends on multiple factors, including size, 
clearance rate and shear stress [99]. The size distribution of MBs have been 
determined to be between 1-2µm, while previous investigation have set the blood 
halflife to be 10 mins. While these insights have all been generated in tumor models 
with relatively small blood vessel and low shear stress, the translation into major 
arteries is still currently uncertain. The first aim of this dissertation is to evaluate the 
potential of MB application in high shear stress areas such as major arteries. 
3.3.1 Marker screening 
 
Inflammation and upregulation of inflamational biomarkers are precursors to the 
disease progression of atherosclerosis and cardiovascular-related diseases,.  
In order to find a suitable target for MB binding, immunohistological sections of 
TNFα-stimulated carotid arteries were stained for five prominent endothelial 
inflammation markers: ICAM-1, VCAM-1, P-Selectin, E-Selectin and PECAM-1 
(Figure 15).  
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Figure 15. Immunofluorescence staining of murine carotid artery sections. 5 µm paraffin sections of 
murine carotid arteries after TNFα stimulation cut and stained for ICAM-1, VCAM-1, E-Selectin, P-
Selectin and CD31 (green). Antibody isotype control are shown for each marker. The arterial lumen 
faces top. Low level expression are indicated by arrows (red). Scalebar = 50 µm. 
 
Based on fluorescence intensity quantification and area fraction, P-Selectin and 
VCAM-1 were both hardly detectable on the endothelium, neither before nor after 
stimulation. ICAM-1, E-Selectin and PECAM-1 showed a significant upregulation 
(p < 0.001). In comparison, ICAM-1 appears to have the strongest increase upon 
stimulation and has been chosen for that reason to be the model-targeted for further 
investigations (Figure 16). It has already been demonstrated by numerous studies, that 
ICAM-1 upregulation is associated with acute and chronic inflammation of the 
endothelium which in turn can facilitate leukocyte recruitment and translocation [118, 
119]. 
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Figure 16. Quantification of immunofluorescence stainings of endothelial surface markers. The 
mean fluorescence intensity for ICAM-1, VCA0-1, P-Selectin, E-Selectin and CD31 were measured 
using Image J and normalized with the area fraction. Three separate groups were analyzed: 1. After 
TNFα stimulation, without TNFα stimulation and IgG control. *** p < 0.0005. Errorbars indicate 
standard deviation. 
 
3.3.2 In vitro validation 
 
Initially, the inflammation model induced in wild type mice has to be validated in 
vitro. Both constitutional and stimulated expression of ICAM-1 were determined. 
Human Umbilical Vein Endothelial Cells (HUVEC) were stimulated with gradually 
increasing concentrations of TNFα and stained for ICAM-1 expression in order to 
find the optimal dosage. While 10 ng/mL did not elicit any cellular response after 6 
hours of stimulation, 20 ng/mL and 40 ng/mL increased ICAM-1 expression 
significantly, while no further significant differences could be observed with higher 
concentrations. Corresponding to the immunohistological murine slides, HUVEC also 
showed a significant increase of ICAM-1 expression (Figure 17). 
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Figure 17. Live cell fluorescence staining of human Umbilical Vein Endothelial Cells.  HUVEC cells 
stimulated without of with different concentrations of TNFα (0, 10, 20 and 40 ng) were stained for 
ICAM-1 expression (red). The cell surface and nucleus were stained for better orientation and analysis 
(green and blue, respectively). Scalebar = 25 µm. 
 
Using customized flow chambers, HUVEC stimulated with 40 ng/mL TNFα for 6 
hours were used for in vitro binding studies at low flow rates. Based on the 
dimensions of the flow chamber and applied flow rate of 0.25 mL/min, the shear 
stress applied onto the cells was 1.25 dyn/cm2, which is approx. 50 fold lower than in 
murine arteries and 10 fold lower than in human arteries. However, higher shear stress 
would induce the detachment of cells. For the purpose of binding specificity, high 
shear stress conditions were not necessary.  
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Figure 18. Statistical analysis of MBICAM-1 in vitro binding assay. Image analysis using ImageJ 
showing the number of bound MBICAM-1 per cell for conditions under TNFα stimulation and without. 
Error bars indicate standard deviation. *** p < 0.0005. 
 
The number of bound MB was determined using epifluorescence microscopy, 
showing that ICAM-1 targeted MB bound with an 8 fold higher efficiency to 
stimulated HUVEC than unstimulated or non-targeted MB. The control groups using 
non-stimulated cells and non-targeted MB showed no significant differences between 
each other (Figure 18). Additional z-stacked images were recorded using TPLSM. 
3D-reconstructions of these z-stacks confirm direct interaction between cells and MB 
(Figure 19). 
 
Figure 19. Fluorescence and two-photon microscopy images of MBICAM-1 binding assay. Wide field 
fluorescence microscopy show A) the binding of MBICAM-1 with HUVECS under TNFα stimulation and 
B) their absence without TNFα. C) High resolution images recorded using TPLSM show the surface 
binding of MB in detail and D) the side view reveals that the MB binding follow the topography of the 
cell layer. Scalebar = 25 µm. 
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3.4 Ex vivo artery binding assay 
 
Parts of the following section have been published as: 
Z. Wu*, A. Curaj*, S. Fokong, E.A. Liehn, C. Weber, T. Lammers, F. Kiessling, M. van Zandvoort. 
Rhodamine-loaded ICAM-targeted microbubbles for dual modality imaging under controlled shear 
stresses. Circ Cardiovasc Imaging. 2013;6(6):974-81 (* equal contribution). 
 
For the reproduction of the in vitro results into more physiological conditions, 
additional binding assays were conducted in explanted murine carotid arteries. After 
intraperitonial injection of 1 µg of TNFα and 4 hours of stimulation in wild type mice, 
both carotid arteries were carefully explanted and kept in Hank’s Balanced Salt 
Solution (HBSS) as physiological medium to keep the tissue viable. During the 
mounting procedures, only both ends of the explanted arteries were touched to 
minimize endothelial damage. 
In order to mimic in vitro flow conditions, the initial flow rate for ex vivo perfusion 
was set at 0.25 mL/min. Depending on the radius of the artery the estimated shear 
stress is approximately 15-20 dyn/cm2, 10 fold higher than the in vitro setting. Using 
HBSS as flow media, surprisingly, control experiments using non-specific MB 
showed an 80% retention rate after 10 mins of perfusion while two additional washing 
steps did not significantly lower the unspecific binding of the MB. When switching 
the perfusion media to human whole blood and blocking the artery with blood before 
injection, unspecific retention of MB was reduced to 10% after two washing steps. In 
order to exclude damage to the endothelial glycocalyx during sample preparation as a 
potential reason for unspecific binding, which usually is induced by injection of 
airbubbles, we injected purposefully an air bubble into the mounted artery prior to the 
binding experiments. However, this did not have a significant impact on the binding 
behavior of the MB (Figure 20).  
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Figure 20. Buffer optimization and unspecific binding of untargeted MB. The amount of bound MB 
after perfusion and washing was analyzed using Imaris software. Using different perfusion media, 
unspecific binding was reduced after washing. Error bar represents standard deviation. N = 5 
 
In the next step, flow rate and shear stress was gradually increased to meet and further 
exceed physiological conditions in order to evaluate the kinetics of MB binding for 
ICAM-1. A detailed literature search suggested the average flow rate in murine 
carotid arteries to be between 0.5 and 0.6 mL/min. Therefore, MB binding was 
assessed at 0.25 mL/min, 0.6 mL/min and 0.8 mL/min.  
In agreement with the previous in vitro data at 0.25 mL/min flow, MBICAM-1 binding 
on TNFα stimulated carotids showed a 7.5 fold increased binding to the inflamed 
endothelium compared to non-specific or non-stimulated tissue. Due to blocking and 
perfusion with blood, unspecific binding with untargeted MB was marginal, 
indicating ligand-mediated binding. This was further confirmed by competition 
experiments with free ICAM-1 antibodies. The increase of flow to the physiological 
condition of 0.6 mL/min did not impact MB binding efficiency. However, when flow 
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rates reached 0.8 mL/min and above, MB binding dropped significantly by 38% and 
55%, respectively (Figure 21). 
 
 
Figure 21. ex vivo MB binding kinetics. Quantitative analysis of MB binding were performed at 
different flow rates to analyzed MB binding behavior. The specificity of MB binding was tested at low 
flow rates of 0.25 mL/min for control MB without antibody labeling or without TNFα stimulation and 
under competitive conditions. Gradual increase of flow in TNFα stimulated arteries reveal limitations 
of MBICAM-1. Error bar represents standard deviation. N = 5 
 
In regards to shear stress estimations, the vessel diameter was the only variable due to 
individual variation within the animal groups and the biggest influence on the shear 
stress calculation (Equation 3). Blood viscosity, temperature, and flow rate were fixed 
parameters. Using the algorithm for radius estimation based on the curvature of the 
artery published by Van Triest et al. in 2012 [114], we matched each MB binding 
assay and quantification to the individual shear stress in each carotid artery shown in 
a scatter plot (Figure 22). 
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Figure 22. Shear stress estimation in mounted carotid arteries during MB binding assays. 
 
In general, there are two phases: 1) plateau/saturation phase and 2) linear decline 
phase. MB retention is not affected by shear stress up till 50 dyn/cm2 and linearly 
decrease at high shear stresses.  
 
3.5 Wire injury model 
 
Parts in the following section have been accepted for publication as; 
Z. Wu*, A. Curaj*, S. Fokong, E.A. Liehn, C. Weber, A. Burlacu, T. Lammers, M. van Zandvoort, F. 
Kiessling. Noninvasive molecular ultrasound monitoring of vessel healing following intravascular 
surgical procedure in a preclinical setup. ATVB. (* equal contribution) 
 
After confirming shear stress resistance and the potential application of MB for the 
detection of endothelial inflammation markers, the translation from an artificially 
induced inflammation into a more clinically relevant inflammation model was 
required. 
Interventional surgery is common in clinical routine. Restenosis following 
revascularization procedures is a critical issue during the treatment of patients and is 
the main restricting factor for the efficiency of treatment methods. Similar to the onset 
of atherosclerosis, endothelial dysfunction and inflammation plays a major role during 
patient recovery, which leads to the recruitment of monocytes to the site of 
intervention and ultimately restenosis. Molecular monitoring of endothelial 
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inflammation can provide the essential information on endothelial state and permit 
personalized medication for delayed reendothelialization and thrombus formation. 
The wire-injury mouse model represents accurately the clinical procedures of balloon 
angioplasty and endarterectomy, which severely injures the endothelial layer, leading 
to acute inflammation and exposed arterial smooth muscle cells. 
 
The previous studies involving the wire-injury model have shown endothelial 
regeneration to occur within 3 weeks after vascular intervention. In order to 
characterize the degree of regeneration and inflamational marker expression, whole 
excised murine carotid arteries were mounted and stained for the following time 
points: 1 day, 3 days, 7 days and 14 days after wire injury. Due to partial endothelial 
denudation, not all endothelial inflamational markers are suitable as a molecular 
target. Optimally the marker should be expressed both on the inflamed endothelium 
and the exposed underlying smooth muscle layer. For this purpose, VCAM-1 has 
been chosen as a potential target, due to the before mentioned expression pattern in 
combination with CD31 to characterize endothelial regeneration. 
Using TPLSM, 3-dimensional z-stacks of the carotid artery were acquired showing all 
three layers of the blood vessel: the adventitia, the media and the intima. 
24 h after surgery the vessel lumen was covered by a layer of cell debris showing no 
signs of CD31 staining or VCAM-1. However, SMC VCAM-1 was highly up-
regulated. At three days, first signs of endothelial recovery was visible showing 
VCAM-1 expression on both endothelial and SMC level. With increasing degree of 
endothelial regeneration at 7 and 14 days, VCAM-1 expression was still upregulated 
on the SMC level. However, with increasing endothelial coverage, endothelial 
VCAM-1 also decreased (Figure 23). 
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Figure 23. Ex vivo Immunofluorescence TPLSM imaging of wire-injured murine carotid arteries. 
1 d post surgery, the endothelium is denudated showing cell debris and a strong SMC VCAM-1 
upregulation. At 3 d, the onset of endothelial recovery can be observed showing colocalization of 
CD31 and VCAM-1. At 7 d, the endothelium has recovered partially. After 14 d, the complete 
endothelium has regenerated. Red = VCAM-1, Green = CD31, Blue = SYTO 41. Images were analysed 
using Image Pro 7.0. Scale bar = 50 µm. 
 
Based on its expression pattern, VCAM-1 seems to be a very promising candidate for 
further investigations. 3-dimensional reconstruction of the image stacks recorded at 
different time points give a clearer picture showing almost complete 
reendothelialization in mice after only 7 days. VCAM-1 as a marker is only surface 
accessible during the first 7 days, due to the exposure of the SMC layer and the early 
activation of the regenerating endothelial cells (Figure 24). Data analysis revealed that 
endothelial coverage to reach 20% after 3 days, 80% after 7 days and 100% after 
14 days. Colocalization between VCAM-1 and CD31 is only occurring at 3 days after 
surgery, due to the overlap of acute inflammation and endothelial regeneration. At 
day 1, no endothelium is present and at day 7 the regenerating endothelial cells are 
not activated anymore (Figure 25). 
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Figure 24. 3-dimensional rendering of wire-injured carotids. Z-stack images were reconstructed 
using Imaris 5.0 to visualize endothelial regeneration and VCAM-1 exposure. While VCAM-1 is fully 
accessible at 1 d and 3 d, the endothelium at 7 d post surgery has mostly recovered. Scale bar = 50 
µm. 
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Figure 25. Statistical analysis of endothelial recovery and VCAM-1 expression. A) Gradual recovery 
of the endothelial based on 3-dimensional rendering of the CD31 signal over 14 days post surgery. B) 
Colocalization analysis of VCAM-1 with CD31 indicating endothelial VCAM-1 to be present only on 
day 3 post surgery. Error bar represents standard deviation. N = 5. 
3.6 Ex vivo binding study targeting VCAM-1 
 
Parts in the following section have been accepted for publication as; 
Z. Wu*, A. Curaj*, S. Fokong, E.A. Liehn, C. Weber, A. Burlacu, T. Lammers, M. van Zandvoort, F. 
Kiessling. Noninvasive molecular ultrasound monitoring of vessel healing following intravascular 
surgical procedure in a preclinical setup. ATVB. (* equal contribution). 
 
The extend and specificity of MB binding was furthermore confirmed within the ex 
vivo flow chamber model using excised murine arteries after wire injury. The 3 day 
time point was chosen due to the highest exposure and expression of VCAM-1. 
MBVCAM-1 retention was 6.7 fold higher in injured arteries compared to healthy blood 
vessels and 8.7 fold higher than under competition conditions using free VCAM-1 
antibodies. After the MB binding assay, the carotids were stained with anti-VCAM-1 
antibody, showing bound MBVCAM-1 to be colocalized with the VCAM-1 signal, 
confirming binding specificity.  
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Figure 26. Ex vivo flow chamber validation of MBVCAM-1 binding. Binding assay was performed at 
3 days post injury with the highest endothelial VCAM-1 expression. A) Healthy/uninjured, wire-injured 
and wire-injured arteries under competition conditions were perfused with MBVCAM-1 and co-stained 
with CD31, bound MB (red) are indicated by arrows. B) Subsequent VCAM-1 staining after MBVCAM-1 
binding show colocalization with VCAM-1 staining. C) Quantitative analysis of MBVCAM-1 binding. 
Scale bar = 50 µm. Error bar represents standard deviation. *** p < 0.0005 N = 5. 
3.7 In vivo targeting of VCAM-1  
 
Parts in the following section have been accepted for publication as; 
Z. Wu*, A. Curaj*, S. Fokong, E.A. Liehn, C. Weber, A. Burlacu, T. Lammers, M. van Zandvoort, F. 
Kiessling. Noninvasive molecular ultrasound monitoring of vessel healing following intravascular 
surgical procedure in a preclinical setup. ATVB. (* equal contribution) 
 
Injections of MBVCAM-1 into live animals were performed in order to verify its 
application under physiological flow and clearance conditions. Both injection, 
clearance and binding were observed via a surgical window created for in vivo 
TPLSM in the collar region on top of the carotid artery. Almost immediately after the 
bolus injection of 4x107 MBVCAM-1 the influx could be observed. Due to limitation of 
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image acquisition rate and respiratory movements, bound MB cannot be distinguished 
from free flowing MB during injection phase. 
 
Figure 27. In vivo TPLSM imaging of the bolus MB injection of nontargeted MB. Over the time 
period of 3 mins, the clearance of non-targeted MB was observed.  Scale bar = 50 µm. 
 
After 5 mins, the majority of MB were cleared out of the circulation (Figure 27). 
While MBVCAM-1 did not bind to the vessel wall, bound MB were detected on the 
luminal side of animals which underwent wire injury 3 days prior to imaging. Using 
post processing and image sorting, individual MB were bound to the same location 
over the observed time period of 5 mins. Even after euthanasia, excision and 
mounting of the carotid, the MB were still present in the lumen (Figure 28). 
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Figure 28. In vivo injection and binding of MBVCAM-1 to injured murine carotid artery. A) 3 days post 
wire injury 4x107 MBVCAM-1 were injected into the blood circulation. B) After clearance of unbound 
MB, stationary bound MB (red) can be observed (indicated by arrows) over the time period of several 
minutes. Scale bar = 50 µm. 
3.8 Validation using molecular ultrasound  
Parts in the following section have been accepted for publication as; 
Z. Wu*, A. Curaj*, S. Fokong, E.A. Liehn, C. Weber, A. Burlacu, T. Lammers, M. van Zandvoort, F. 
Kiessling. Noninvasive molecular ultrasound monitoring of vessel healing following intravascular 
surgical procedure in a preclinical setup. ATVB. (* equal contribution). 
 
Data validation and Ultrasound measurements were performed by Dr. med. Adelina Baleanu-Curaj. 
 
Using high-resolution and deep tissue imaging for the characterization of MB binding 
kinetics, specificity and shear stress resistance created a foundation for the translation 
into clinical modalities. Based on the encouraging results collected using TPLSM, 
validation using molecular ultrasound was performed. The detection of MB via 
ultrasound is based on the air encapsulated inside of the particles, which oscillates 
upon sonification providing a high degree of echogenicity. The quantification of 
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bound MB was performed using a high power destruction pulse, clearing the entire 
field of view and represented in the decrease of gray scale intensity. 
ICAM-1 and VCAM-1 targeted MB were used in combination with non-invasive 
molecular Ultrasound for preclinical validation. MB binding was initially imaged in 
ex vivo flow chambers to validate US sensitivity and detection limit. Compared to 
previous TPLSM results, similar results and trends were observed. A significantly 
contrast enhancement (~8 fold increase) was generated from bound MB to either 
TNFα stimulated tissue by MBICAM-1 or injured tissue using MBVCAM-1 compared to 
controls (Figure 29).  
 
 
Figure 29. US validation ex vivo. Both A) ICAM-1 and B) VCAM-1 targeted MB were tested in ex vivo 
mounted carotid arteries after 4h of TNFα and 3 days after wire injury surgery, respectively. In both 
models, MB binding was significantly higher using targeted MB and under stimulation and injury 
condition, respectively. * p < 0.0005, ** p < 0.001. 
 
Furthermore, to test whether molecular US can be used to track endothelial 
regeneration in vivo in the same animals, ApoE-/- mice were put on a high cholesterol 
diet one week prior to endothelial injury to induce hyperlipidemia, which is the 
physiological condition after vascular intervention in patients. Using VCAM-1 
targeted MB, significant binding was detected at 1,3 and 7 days post surgery, peaking 
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at day 3 (Figure 30), while at later time point no contrast enhancement could be 
detected at the site of injury site.  
 
 
Figure 30. In vivo US measurement using VCAM-1 targeted MB, 3 days after wire injury surgery. 
After MB injection the entire carotid artery (outlined in yellow) is flooded with MB (red). 7 min after 
injection, the majority of MB have been cleared out of the circulation, leaving only bound MB (white 
arrows). The MB binding quantification is based on a destructive pulse, destroying all bound MB in the 
field of view. 
 
The US data correlate strongly with TPLSM immunohistology and quantification of 
endothelial coverage and regeneration, which show luminal exposure of VCAM-1 at 
day 1, 3 and 7. The endothelial recovery is completed at day 14. Endothelial 
regeneration rate is influenced by various factors, such as diet, mediation and age. 
Further investigations were carried out using ApoE-/- mice on a 12 week diet prior to 
endothelial injury, which develop early stage atherosclerotic plaque. Similar results 
were collected, showing significant binding of MBVCAM-1 to the injured lumen at 1, 3 
and 7 days. In comparison to the 1-week diet animals, MB binding was higher by the 
factor of 5 at day 7, which indicates a delayed reendothelialization due to the 
prolonged high fat diet and denudated plaque area (Figure 31).  
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Figure 31. US quantitative comparison of animals on 1 week of diet versus 12 weeks of diet prior to 
wire injury surgery. With the 12 week diet, the binding of VCAM-1 targeted MB was significantly  
higher at day 3 and 7 compared to 1 week diet animals. A higher degree of binding at later time points 
indicate a higher degree of inflammation as well as a delay of reendothelialization. 
 
Significant binding on control animals without injury was not detected, even though 
early stage plaque have a high VCAM-1 expression. However, immunohistological 
quantifications have shown that plaque area only constitutes for 3% of the total 
luminal surface.  
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4 Discussion 
 
Contrast agent and drug development is a labor intensive and highly complex 
procedure, including seemingly endless screening and validation steps on in vitro, ex 
vivo and finally in vivo level. The feasibility of microbubbles as a molecular contrast 
agent for Ultrasound has already been proven in the field of tumor imaging and other 
organs such as the liver, where MB can accumulate due to low flow conditions or 
tissue specific properties that favor MB retention. However, the binding of particles in 
high shear stress areas such as major arteries is a major challenge.  
The binding efficiency of a particle is determined by four major factors: 1) the affinity 
constant of the formed bond, 2) size of the particle, 3) the bioavailability of surface 
markers, and the shear stress at the binding location [120, 121].  
 
Table 2. Bond dissociation rates of integrin and CAM bonds under different conditions 
 
Ligand Bond dissociation rate [s-1] 
P-Selectin 2.85-1.17 [122] 
L-Selectin 125.4-2.27 [122] 
I-CAM-1/LFA (low affinity conformation) 4 [123] 
I-CAM-1/LFA (high affinity conformation) 0.17 [123] 
I-CAM-1/LFA (high affinity conformation) + Mg2+ 0.008 [124] 
 
Mimicking the binding behavior of leukocytes, which expresses both CAMs and 
selectins, it is apparent that not only one, but multiple ligands are needed for efficient 
binding.  When multiple bonds form between cells and a surface, these effects can 
greatly enhance the bond lifetime.. During leukocyte adhesion, selectins are 
predominately the type of ligands that is suggested to promote rolling and the 
slowdown. Formed “catch and slip bonds” by selectins show relatively low affinity, 
reflected in the dissociation rate of the bond (Table 2), however their affinity curve 
shows that, bond strength increases with shear force until their shear optimum (catch) 
and gradually decreases (slip), decreasing rolling velocity of leukocytes thereby 
increasing the probability of new bonds between cell and endothelium [122]. CAMs 
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receptors on the other side undergo conformational change upon binding, increasing 
their affinity by a magnitude of >100 fold, arresting the cell, given enough time [123]. 
The size of contrast agents impact greatly on clearance rate, biodistribution and 
cellular uptake. Nano-sized contrast agents show prolonged circulation time and 
promote receptor-mediated and unspecific internalization and extravasation into the 
tissue [125], protecting them from the shear forces in the lumen. However, this makes 
the differentiation between marker-specific and unspecific uptake very difficult. MB 
with an average size of 1.5 µm and a hard shell lack the flexibility of leukocytes, thus 
they cannot migrate and consequently remain exclusively in the vascular 
compartment, which makes these particles ideal endothelial contrast agents. 
Nevertheless, MB size and rigidness make them more prone to collisions with blood 
components and breaking, therefore blood flow and shear stress play a limiting factor 
in the retention rate of these particles. 
The aim of this dissertation was to investigate the bioavaiability and binding 
efficiency of endothelial markers and their feasibility for MB binding.	  
4.1 MB synthesis and characterization 
 
MB synthesis and characterization is a crucial step towards clinical applications. 
Particle size has a major impact on cellular uptake pathways, clearance rate, binding 
efficiency and shear stress resistance. With an initial broad peak of size distribution 
after MB synthesis, MB fragment and sub-micron sized MB were removed during 
centrifugation. The reason that smaller MB are more disturbing than larger particles, 
is their longer circulation time. Contrast-enhanced ultrasound is based on the 
destructive pulse, which destroy any MB in the field of view. In the optimal case, 
there should be no circulation MB in the blood stream so that contrast is only 
generated by the rupture of specifically bound MB.  
The loading of MB with rhodamine into the shell promotes imaging with TPLSM and 
other fluorescence modalities is the first step towards the possibility of drug loading 
for therapeutic purposes. Even though the MB shell is hydrophobic, previous studies 
have shown that both hydrophilic (rhodamine) and hydrophobic (coumarine) 
molecules can be efficiently incorporated into the shell without major release [126]. 
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For the initial proof-of-concept study and animal studies, we chose to use streptavidin 
as our ligation handle, because it is the most simple and fastest conjugation method, 
which only requires the biotinylation of the antibodies. Nonetheless, using 
streptavidin in a clinical setup is not possible due to its immunogenicity. Direct and 
covalent conjugation of targeting peptides or antibodies have already been 
successfully tested in vivo, such as glycine amino acid linkers [127] or potentially 
“click”-chemistry and pose a viable alternative for human trials. 
4.2 Marker screening and in vitro binding assay 
 
The identification of specific markers for disease detection is one of the major 
obstacles during the development of molecular contrast agents. Disease specific 
upregulation and low constitutional expression is desired, but never the case. 
Atherosclerosis and chronic inflammation-induced disease progression is highly 
complex which can only be sufficiently induced using long-term high cholesterol diet 
restrictions.   
During our marker screening in the in vitro and ex vivo model, we found that 
intracellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 
up-regulation was the strongest towards TNFα stimulation. The up-regulation in 
response to proinflammatory stimulation has been described in previous studies in the 
context of endothelial dysfunction [128, 129]. Even though, E-Selectin expression 
was described to be triggered by TNFα, a significant increase was not observed, this 
could be due to the fact the endothelial cells release soluble (s)E-Selectin and thus are 
not present on the surface for a prolonged time period [130]. In the case of PECAM-1, 
studies suggest that it is primarily its up-regulation is concentrated at the intercellular 
borders and does not present a viable candidate for luminal targeting with micro-sized 
particles. Although, previous studies suggest redistribution of PECAM-1 upon 
inflammatory stimulation, it is unknown by what mechanism, where and for what 
stage of inflammation it is distributed on the cell surface [131]. 
Our data suggests that in this simplified, single-trigger, stimulation model using 
TNFα, ICAM-1 presents the most suitable target, due to low constitutional expression 
level and high level of stimulation-induced expression. Proceeding to the in vitro 
binding assays, ICAM-1 upregulation was observed on human umbilical vein 
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endothelial cells after TNFα stimulation as well. After confirming binding specificity, 
we used TPLSM for three-dimensional cell imaging. On top of wide-field 
fluorescence images, the z-dimensional information confirmed direct cell-to-MB 
contact, ruling out potential unspecific interactions between the polymeric MB and 
the cell dish. 
4.3 Ex vivo shear stress resistance 
 
With high numbers of studies in tumor-bearing mice, the MB binding using vascular 
endothelial growth factor receptor (VEGFr) has been established as a reliable contrast 
agent for preclinical research and is currently undergoing clinical trails [132]. 
However, the application in high shear stress areas was never tested. The ex vivo 
perfusion chamber using fresh tissue allows the exploration of shear stress limits of 
the MB using different targets under controlled conditions. 
The shear stress within blood vessels is determined by many factors, such as vessel 
diameter, flow rate, blood viscosity and vessel architecture [133]. As a result, the 
shear stress is variable thoughout the entire blood vessel [134]. Not suprisingly, shear 
stresses found in the literature for murine carotids range between 28 – 142 dyn/cm2 
[135]. However, the predominant part of publications determine the shear stress 
within murine carotid to be in the range of 36 – 81 dyn/cm2 at average flow rates 
between 0.35 – 0.75 mL/min [136-140]. Therefore, the entire range starting from 
0.25 mL/min – 1 mL/min was covered for the binding assays of ICAM-1 targeted 
MB. 
Regarding the flow rate, the study shows that ICAM-1 targeted MB bind to activated 
endothelium at flow rates up to 0.6 mL/min without significant reduction of binding 
efficiency, which reflects the average in vivo conditions in murine carotid arteries. 
While at higher flowrates of 0.8 and 1 mL/min the binding reduction is linear and 
drops by 38% and 55% respectively. When considering the individual binding values 
in regards to the estimated shear stress for every artery and their radius, the MB 
binding seems to decrease exponentially with increasing shear stress.  
Similar studies using in vitro flow studies and immobilized binding targets show that 
ICAM-1/LFA-1 forms a strong bond [141, 142], which is also indicated by the bond 
strength and the conformational change after bond formation which increases binding 
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affinity by the factor of 100. Hypothetically, bond rupture should occur sudden when 
shear stress and hydrodynamic force exceed bond strength and therefore lead to an 
instantaneous break of all bonds formed between the endothelium and the 
microbubble. In a model where the availability of surface targets are controlled, this 
might be the case. However, in an ex vivo or in vivo setup using MB there is more to 
consider. First of all, ICAM-1 availability within the entire blood vessel is not 
homogeneous upon TNFα stimulation. Secondly, ICAM-1 is reported to form clusters 
which induce leukocyte arrest and extravasation [143, 144]. Thirdly, shear stress is 
not a constant parameter within a blood vessel, local shear stress can vary and 
therefore favour or adversely effect MB retention [145]. Lastly, PBCA-MB are hard-
shelled particles with limited flexibility, limiting also their surface-endothelium 
contact area and the amount of bonds formed. The binding of ICAM-1 targeted MB 
from an activated endothelium depends on the availability of binding targets, and the 
detachment of an individual MB is dependent on the local shear stress and the number 
of formed bonds. A linear, but not abrrupt decrease of MB binding with increasing 
shear stress is in good agreement with our data. 
 It is important to note that, for future clinical application, shear stress in carotids is 
inversely related to the body weight and decreases from mice to humans by a factor of 
6, ranging between 9.5 and 12.4 dyn/cm2 [146]. We have shown in this ex vivo study 
that ICAM-1 targeted MB are capable to withstand shear stress in major arteries under 
physiological conditions in patient. 
4.4 Wire injury and VCAM-1 expression 
 
Arterial stenosis is the consequence of chronic inflammation of the arterial wall and 
atherosclerosis. Intervention therapy restores blood flow by either surgically 
removing the plaque or by squeezing it via a balloon or stent, injuring or even 
removing the endothelial layer of the blood vessel. As the regulatory functions of the 
endothelium, such as anti-thrombotic or anti-inflammatory, are not present, 
complications such as neointima formation, restenosis and thrombus formation can 
occur after intervention. The degree of endothelial regeneration after intervention 
correlates to the risk of complications and precludes the success of the interventional 
therapy. With standardized medication period, dosage, and combination, individual 
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factors that impact the patients recovery rate such as, age, immune state, plaque size 
and other pathologies such as diabetes are not taken into consideration [147-150]. 
Currently, there are no monitoring models available to accurately track the degree of 
endothelialization, leading to either prolonged medication periods or early termination 
of medication. Therefore, clinical follow-up and personalized medication are the key 
to patient recovery. 
Due to the nature of interventional surgery, the ideal molecular marker should be up-
regulated on both the smooth muscle cells and endothelial cells. The removal of 
endothelial cells exposes the underlying smooth muscle cell layer to blood flow, 
followed by gradual recovery of the intimal layer. Vascular adhesion molecule 1 is a 
well characterized protein linked with inflammatory diseases, leukocytes recruitment, 
and early and advanced stages of atherosclerosis, which is usually associated with 
endothelial dysfunction [151, 152]. However, VCAM-1 can also be expressed by 
smooth muscle cells [153-155], for examples after injury.  
Longitudinal image stacks obtained using TPLSM show VCAM-1 expression along 
the blood vessel in two of three layers not only on regenerating and residual 
endothelial cells but also strongly on the medial smooth muscle cells. A previous 
study by Manka et al. [156] showed comparable results indicating VCAM-1 as a 
major contributor to the regeneration process of the arterial wall [156]. Furthermore, 
medial VCAM-1 up-regulation after arterial injury promotes neointima formation and 
smooth muscle proliferation and consequently vessel restenosis.  
During revascularization procedures, the endothelial layer is getting severely injured, 
resulting in an acute inflammatory response of both the residual remaining endothelial 
cells and the sub-endothelial SMCs. In our murine model, the sub-endothelial layer is 
highly inflamed leading to an instantaneous tissue response and VCAM-1 expression 
already 1 day after surgery. With progressing regeneration from residual and bone 
marrow derived endothelial cell after 3 days, inflammation is still present leading to 
VCAM-1 expression on both endothelial cells and smooth muscle cells. It was the 
only time point during which VCAM-1 expression was found on endothelial cells. It 
is likely that injury induced acute inflammation and partial endothelial reorganization 
overlap at day 3. After one week, the newly formed endothelial layer is covering more 
than ¾ of previous injury site. Even though SMCs are still expressing VCAM-1 on a 
high level, the majority of the markers are not superficially available/targetable 
anymore. 
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Figure 32. Schematic presentation of the endothelial healing and MB binding process. A healthy 
endothelium does not express VCAM-1. Only after endothelial denudation and during the acute injury 
phase, both remaining endothelial cells and exposed smooth muscle cells express VCAM-1, which can 
be targeted by MB. With ongoing endothelial recovery, endothelial activation diminishes as well as the 
SMC area exposed to the lumen resulting in less binding spots for MB. Finally a completely healed 
endothelium does not promote MB binding due to inaccessibility of VCAM-1 on the underlying SMCs. 
 
Microbubbles are rigid and too big to extravasate, which makes them a perfect 
intravascular targeting agent. VCAM-1 is present during the acute stages of injury on 
both SMCs and endothelial cells, however its surface availability decreases with the 
increasing coverage of the SMC, which can be used to monitor the degree of 
reendothelialization (Figure 32). 
4.5 Clinical validation using molecular ultrasound 
 
Molecular Ultrasound was chosen to validate TPLSM results collected both ex vivo 
and in vivo. The rhodamine-loaded MB are a bi-modal contrast agent that allows 
fluorescent detection via two-photon excitation and also ultrasound detection via 
destruction. This setup allows a smooth translation between both modalities. 
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We showed in the previous investigation using TPLSM that MBICAM-1 in a simplified 
model of endothelial inflammation induced by TNFα can bind specifically to the 
lumen withstanding shear stress at and exceeding physiological conditions. Further, in 
a mouse model of endothelial denudation, similar to clinical vascular intervention 
such as endarterectomy and balloon angioplasty, we identify VCAM-1 as a potential 
target for monitoring endothelial regeneration. The selection of the targeting moiety 
should ideally fulfill three criteria’s: 1) overexpression on activated residual and 
regenerating endothelial cells, 2) absence or low expression before and after 
endothelial regeneration and 3) subendothelial overexpression after endothelial injury 
and denudation. 
Based on previous publications, the majority of the well-characterized inflamational 
markers do not qualify. Naturally, Selectins and cell adhesion molecules are 
overexpressed during endothelial activation. However, PECAM-1, ICAM-1, P-
Selectin and E-Selectin have a significant constitutional expression level [157-161]. 
Moreover, some markers such as PECAM-1, E-Selectin, P-Selectin are not 
sufficiently upregulated on activated VSMCs [158, 162, 163], or remain to be 
overexpressed for a prolonged time period after complete endothelial recovery 
(PECAM-1, ICAM-1) [159]. TPLSM imaging of denudated arteries show VCAM-1 
overexpression on both the VSMCs and the regenerating endothelial cells. With 
progressing endothelial overage, the availability of luminal accessible VCAM-1 
decreases, even though expression levels of VSMCs is still high. As MB are a 
exclusively luminal contrast agent, it cannot penetrate or extravasate into the 
subendothelium, thereby are perfectly suited for imaging of endothelial regeneration. 
MB binding detection in vivo in animals using molecular US was conducted in two 
ApoE-/- mice groups which were put on a high cholesterol diet for either 1 week or 
12 weeks prior to endothelial denudation and imaged for the following 2 weeks. After 
1 week, the animal develop hyperlipidemia, which is the predominat physiological 
conditions in patients after vascular intervention. In contrast, animals on 12 weeks of 
diet display signs of early plaque development and higher content of immune cells in 
the subendothelium. It was our interest to determine, whether molecular US could 
track endothelial regeneration in both models and distinguish alteration in the course 
of healing. In fact, molecular US was able to detect significant binding of at 1, 3 and 
7 days post denudation, where according to TPLSM immunohistology the 
endothelium was still not fully recovered. Interestingly, the contrast enhancement in 
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animals on 12 weeks of diet prior to endothelium denudation was higher by 65% at 
day 3 and by 570% at day 7, compared to animals on only 1 week of diet, which is 
due to enhanced binding of MBVCAM-1. This is not surprising, as high fat diet and 
obesity related pathologies such as diabetes can interfere and delay wound healing, 
cell proliferation and angiogenesis in combination with a prolonged and enhanced 
inflammatory phase, both in animals and patients [164-166].  
In this study, we have only examined one of many factors that can alter the 
regeneration rates of injuries and wounds. But molecular US was capable to reliably 
detect a prolonged inflammation phase and delayed inflammation. In the clinic setup, 
single or a combination of multiple systemic factors can be the trigger for delayed 
regeneration. First, patient age is one the most prominent factor. The majority of 
patients undergoing vascular intervention are elderly and delayed endothelial recovery 
can occur due to altered platelet aggregation, decreased secretion of growth factors 
and an altered inflammatory response to injury based on reduced phagocytic activity 
and delayed T-cell infiltration. Additionally, patients receive medication after 
vascular intervention such as anti-platelet and pain medication that can inhibit 
platelets adhesion, tissue inflammation and cell proliferation. Moreover, existing 
diseases accompanying cardiovascular problems, such as diabetes can lead to tissue 
hypoxia and oxidative stress which severely impair regenerative functions. Lastly, 
there are factors beyond estimation and measure, such as stress, smoking, alcohol 
consumption and nutrition. 
Tissue and endothelial regeneration is a multifactorial process, which makes the rate 
of post interventional healing nearly unpredictable. An underestimation of endothelial 
recovery leads to prolonged anti-platelet and anti-thrombotic medication, bearing 
risks for major bleedings and a limitation of medical procedures during medication 
periods. More importantly, an overestimation of endothelial recovery leads most 
likely to thrombosis and a life-threatening event. US imaging is cheap, non-radiative, 
non-invasive and bedside available. In combination with molecular specificity and a 
vascular contrast agent, we show that MB are suitable to track endothelial 
regeneration.   
VCAM-1 is first and foremost known as an atherosclerotic marker. Having animals 
on 12 weeks of high cholesterol diet with early stage plaque growth, we were able to 
also test MBVCAM-1 for the diagnosis of early stage atherosclerosis. However, 
significant MB binding was not detected. Given the size and the degree of plaque, this 
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is not surprising. The early stage plaque areas made up only 3% of the total 
endothelial surface, which is marginal compared to the conditions after vascular 
intervention. Each imaging modality has limitation regarding resolution and 
sensibility. Respiration and vascular contractions contribute mainly to the background 
noise level, when using ultrasound, which decreases the signal-to-noise ratio and 
sensibility.  
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Z. Wu, T. Rademakers, F. Kiessling, M. Vogt, E. Westein, C. Weber, R.T.A. Megens, M. van Zandvoort. 
Non-linear Laser Scanning Microscopy in Cardiovascular Research. Cardiovasc Res. 
 
Many different contrast agents have been designed and evaluated over the years. Only 
very few have managed to progress into clinical trails. This is mainly due to their 
complexity and multifactorial nature of specificity, clearance, uptake and toxicity. 
The aim of this thesis therefore was to establish Two-photon microcopy as a 
preclinical transitional tool for the evaluation of novel contrast agents for their 
potential clinical application. 
The incorporation of fluorescent dyes into contrast agents make them suitable for 
hybrid imaging using clinical and optical imaging modalities. In this case, air 
encapsulated in the core of the particle enabled ultrasound detection and rhodamine 
loaded into the particle shell promoted optical detection. The characterization of 
microbubbles and other particles in general require a streamlined process from in 
vitro to ex vivo and finally in vivo, with validation at each step to ensure its final 
application in the clinical modality. 
Using TPLSM, binding of targeted MB was carefully evaluated using simplified 
single factor models such as the TNFα stimulation model in vitro and step-by-step 
translated into the ex vivo artery model. Shear stress is the biggest obstacle for particle 
retention in major arteries. Deep tissue microscopy enabled MB characterization on 
whole vital arteries under physiological conditions. Not only do MB bind under 
physiological conditions, but also at shear stress conditions exceeding that. 
Furthermore, translation into a clinically relevant model of endothelial injury was 
eased by 3D-topography and quantification of the luminal surface using TPLSM. 
Both 3D expression patterns of VCAM-1 as targeting ligand and regeneration rate of 
the endothelial layer was determined to establish a reference or correlation for US 
applications. In a final step, TPLSM was applied in vivo to observe clearance and 
binding of MB in live animals. All of the above created a foundation for the 
translation into the noninvasive clinical imaging modality. Based on this, molecular 
Ultrasound was successfully applied to non-invasively monitor the endothelial state 
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after injury of the blood vessel. Diet induced delay of reendothelialization was 
accurately detected, which implicates that US in combination with MB  could be 
potentially used as a cheap, bedside available, non-invasive and non-radiative method 
to track the endothelial state in patients after intervention, in order to personalize 
therapy and  improve risk assessment.  
In addition to TPLSM, there are a great spectrum of exploratory studies in non-linear 
microscopy that are currently not applied in cardiovascular research but show great 
potential are, for example hybrid systems combining TPLSM with non-invasive 
imaging modalities such as photoacoustic imaging for label-free tissue imaging based 
on tissue scattering and absorption [167], and RESOLFT (Reversible Saturable 
Optical Fluorescence Transitions)  based the generalization of the STED principle 
using switchable proteins and dyes achieving resolution up to 4 times higher than the 
diffraction barrier [168]. 
In many cases, the ultimate goal of exploratory work in non-linear imaging is to 
translate those insights towards the development of in vivo and clinical diagnostic and 
therapeutic tools. Although the feasibility of in vivo applications for cardiovascular 
research has been demonstrated in animals, to our knowledge there have been no 
reports on its application on human subjects. Until now, clinical non-linear imaging 
has almost exclusively been used on human skin both ex vivo and in vivo [169-171]. 
Due to limited light penetration through the skin, in vivo cardiovascular non-linear 
imaging requires procedures to expose the tissue of interest and create a surgically 
embedded optical window or the application of an endoscope. 
As already developed and established a decade ago, the combination of fluorescence 
imaging and endoscopy offers the possibility of non- or minimal invasive imaging in 
humans [172]. Contradictory to the high numbers of single-photon confocal 
microendoscopy studies in humans and increased usage in clinical routine [173-177], 
there has been only one TPLSM study in humans [178]. The major challenges are the 
efficient delivery of femtosecond excitation light without major degradation, the 
wide-field collection of the multiphoton fluorescence, miniaturization of objective 
lenses and the endoscope itself. Recent technological innovations in photonic crystal 
fibers [179] and imaging lenses (fiber-coupled gradient-index – GRIN lenses) [180] 
have partially overcome these limitations. New Two-photon microendoscopes have 
been developed and tested in animal studies [181-183] and will mostly likely 
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contribute to the development of clinical multiphoton microendoscope prototypes and 
clinical studies outside of the dermatological field in the next years.  
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